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ÛliNtR/lL INTRODUCTION.
The yeara that have passed since the end 
of iorld war II have brought many outstanding 
changes in the practice of anaesthesia. Of 
the alterations that have taken place, one of 
the most obvious has surely been the 
displacement of vaaodepressant agents such as 
dimethyl ether and chloroform by the nitrous 
oxide; oxygen; muscle relaxant sequence with 
endotracheal intubation and intermittent 
positive"pressure ventilation of the lungs. 
This latter method, by virtue of its safety, 
relatively pleasant and rapid recovery, non- 
flarnmabllity and provision of good operating 
conditions for anaesthetist and surgeon alike, 
has come to enjoy almost universal adoption as 
the anaesthetic technique of choice for a 
wide variety of surgical procedures. In 
obstetrical anaesthesia in particular, the 
marked absence of respiratory depression of 
the newborn vi/hen compared with dl-ethyl ether, 
chloroform, trichlore thylene and trimethylene 
(cyclopropane), elects the nitrous oxide; 
oxygen: muscle relaxant sequence as the
usual method of choice.
Such modern methods of anaesthesia Interfere 
little with the integrity of the vasoconstrictor 
mechanism which is relatively free to exercise 
the appropriate response to sympathetic 
stimulation or to circulating pressor substances. 
Vasopressor responses to reflex stimulation and 
to the presence of chemical agents, once 
inhibited or depressed by traditional forms of 
anaesthesia, are now therefore able to exhibit 
themselves to the vigilant observer.
Marked elevation of the blood-pressure is 
undesirable in the normotensive individual under 
general anaesthesia; still more undesirable is 
the occurrence of a further rise in the systemic 
arterial pressure of an already hypertensive 
patient. The validity of this statement is 
borne out by the occasional incidence of 
intracranial vascular catastrophe in this latter 
combination of circumstances.
Deviations from the normal level of resting 
blood-pressure are not uncommon in pregnant 
women, a fact that is not surprising when the 
nujTierous and extensive metabolic changes that
4accompany this process are taken into account. 
Hypertension, occurring as part of the clinical 
picture of pre-eclampsia, not infrequently 
causes anxiety to the obstetrical anaesthetist. 
Drugs selected from the anaesthetic pharmacopoeia 
for administration to toxaemic women must be 
devoid of vasoconstrictor activity, sine© the 
pharmacological activity of vasopressor agents 
is exaggerated in such subjects (Browne, 1946).
The demonstrable occurrence of an elevation 
of blood-pressure following intravenous 
administration of Ergometrine to pre-eclamptic 
women forms not a small part of the burden of 
this thesis.
A number of conditions are commonly 
Included in the term * toxaemia of pregnancy" 
as Is evident from the following list, arranged 
according to the American Committee on Maternal 
^Halfare
X. Acute toxaemia of pregnancy.
A. Pro-eclampsia.
1. mild.
2. severe.
B. Eclampsia (convulsions or 
coma, usually both, when associated with 
hypertension, proteinuria or oedema).
II. Chronic hypertensive (vascular) 
disease with pregnancy.
A. Without superimposed acute
toxaemia•
1. Hypertension known to 
have antedated pregnancy
2. Hypertension discovered 
in pregnancy (before the 24th week and with 
post-partum persistence).
B. with superimposed acute
toxaemia.
III. Unclassified toxaemia (data 
insufficient to differentiate the diagnosis).
Throughout this thesis, the word "toxaemia" 
is Intended to imply acute toxaemia as defined 
in group X.
Pre-eclampsia complicates some 6% of 
pregnancies in the last three months of gestation, 
and is mostly seen in young primigravidae.
The fact that it Is associated with certain 
maternal and foetal hazards has more than a 
little bearing on the theme of this investigation* 
As far as the mother is concerned, the 
immediate prognosis depends largely on whether 
or not eclampsia supervenes, the maternal 
mortality from pre-eclampsia per s© being 
negligible. The occurrence of eclampsia, 
however, presents a maternal mortality in 
the region of
In New Zealand, eclampsia has been a 
notifiable disease for over thirty years and, 
as a result, several interesting surveys have 
been made (Qorkill, 1948, 1954, 1957). Of 
fourteen fatal cases of eclampsia occurring 
during the years 1950 - 55 (Corkill, 1957), 
death was due to massive cerebral haemorrhage 
(5 cases), sudden cardiac failure (5 cases), 
and the accidental haemorrhage - anuria 
syndrome (4 oases). In no case, therefore, 
was death due to the eclamptic state alone.
Maternal prognosis in terms of morbidity 
is much more difficult to assess, but
descriptions of varying types of disability, 
ranging from persistent hypertension to 
cerebral thrombosis with skeletal paralysis, 
occupy not a minute part of the obstetrical 
and general medical literature.
The foetal hazards associated with pre- 
eclampsia are related largely to the severity 
of the disease and to the stage in pregnancy 
at which it first appears. Consideration of 
the foetal problem, however, is not appropriate 
to the present study.
In the light of the possible dangers that 
beset the pre-eclamptic patient, it is obvious 
that the avoidance of any factor that would 
tend to aggravate the existing hypertension is 
of paramount importance. Observation over the 
past few years of the behaviour of the blood 
pressure during operative deliveries has shown 
that, in some women, the intravenous 
administration of Ergometrine gives rise to a 
hypertension of sufficient intensity to cause 
anxiety.
8Several factors arising from this 
observation were in obvious need of examination 
and prompted the inquiry that has its 
culmination in this thesis. A hypertensive 
response appeared to be more frequent in 
hypertensive than in normotensive patients, yet, 
despite this general tendency, the appearance 
of a significant pressor response in some 
normotensive subjects, and the lack of it in 
other hypertensive individuals, seemed to merit 
investigation.
VaSQMQTQK T O m  in h e a l t h .
The degree of contraction of the smaller 
blood vessels is controlled by vasomotor nerves 
belonging to the sympathetic nervous system. 
These nerves are governed by the continuous 
activity of the vasomotor centre which is 
situated in the floor of the fourth ventricle.
B'ibres from the vasomotor centre pass down 
the spinal cord in the white matter of the 
lateral columns to all the thoracic and the
upper two lumbar segments. There, they form 
synapses with the connector cells of the 
sympathetic which lie in the lateral horn of 
grey matter. The vasomotor nerves issue 
from the latter to join the sympathetic chains.
The post-ganglionic fibres take origin in 
the cells of the ganglia of these chains and 
pass therefrom via the grey rami communicantes 
to the somatic nerves*
Vasoconstrictor fibres to the blood 
vessels of the upper limbs are distributed by 
the mixed nerves of the cervical and brachial 
plexuses; those controlling the calibre of 
the arterioles of the lower limbs are carried 
in the mixed nerves from the lumbar and sacral 
plexuses.
The function of the vasoconstrictor 
nerves is to regulate the degree of contraction 
of the Smooth muscle In the walls of the 
arterioles and veins, and consequently to 
determine their calibre, an influence that 
disappears when the nerve supply to the blood 
vessels is abolished.
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This vasoconstriction or tone of central 
nervous origin is produced by direct and reflex 
influences on the vasomotor centre. It may 
be Increased in health as part of an emotional 
response, or as a reaction to sensory 
stimulation by cold or pain#
The discharge of impulses from the 
vasomotor centre Is also influenced by 
affereots from the respiratory centre. During 
the inspiratory phase of respiration, impulses 
radiate from the respiratory centre, causing 
an increase in the activity of the vasomotor 
centre. During the expiratory pause, the 
influence of the respiratory centre on the 
latter is diminished*
An adequate carbon dioxide tension is 
essential to proper functioning of the 
vasomotor centre. Hyperventilation of the 
lungs of the experimental animal reduces the 
carbon dioxide tension in the alveolar air 
and, therefore, in the arterial blood*
Consequently, the vasomotor centre is
11
inhibited, the discharge of impulses down the 
vasomotor nerves is decreased, and dilatation 
of the splanchnic vessels with reduction of 
blood pressure ensues. Inflation of the 
lungs with an atmosphere containing an excess 
of carbon dioxide restores the blood pressure 
to its previous level. The action of carbon 
dioxide on the vasomotor centra is twofold; 
it affects the cells of the centre directly 
and also reflaxly through the chemoreoeptors 
in the carotid and aortic bodies. (Keele & 
Nell, 1961).
Hyperventilation In man, however, need 
not be associated with hypotension. This is 
explained by the fact that hypoearbla exerts 
a direct vasoconstrictor action on the peri­
pheral blood vessels. The effects of carbon 
dioxide on the arterioles are, therefore, 
directly opposite to those produced as a 
result of its central action.
The Initial stimulation of the vasomotor 
centre that results from hypoxia is due partly 
to direct action on the vasomotor centre and
12
partly to reflex stimulation via the 
chemoreoeptors# Unless the hypoxia is relieved 
however, the vasomotor centre will fail rapidly.
Of considerable importance is the Influence 
on the activity of the vasomotor centre of the 
systemic baroreoeptors. These lie in the walls 
of the carotid sinus, aortic arch, pulmonary 
artery, and all four chambers of the heart.
The receptors in the carotid sinus are 
innervated by branches of the glossopharyngeal, 
and the others by branches of the vagus nerve*
A rise in systemic blood pressure causes 
stimulation of alno-aortic nerves and, as a 
result, reflex vasodilatation, a fall in blood 
pressure, and bradycardia. kîihen the blood 
pressure falls, the stimulant effect of the 
nerve endings of the baroreceptors is removed, 
afferent inhibition of the vasomotor centre is 
reduced, and the discharge of impulses down the 
sympathetic vasoconstrictor nerves increased.
In their role of controlling the degree of 
contra^^^-®^ of the arterioles, vasomotor nerves
13
are assisted by the presence In the circulation 
of certain pressor substances, notably the 
catecholamines, adrenaline and noradrenaline. 
These nervous and humoral factors act together 
in the general controlof vascular tone. Local 
modification of arteriolar contraction may also 
result from the presence of metabolites, 
accumulation of carbon dioxide, or changes in 
the hydrogen ion concentration of the Immediate 
environment.
a b n o r m a l INCREASE IN ARTERIOLAR TONE.
Apart from the physiological reflex 
increase in vasomotor tone that may result from 
the application of any strong sensory stimulus 
to the surface of the body, enhanced vascular 
constriction may result from the pharmacological 
activity of pressor substances Introduced into 
the blood stream artificially* Pathologically, 
it may result from the release in abnormal 
amounts of vasoconstrictor substances, from 
increased or altered nervous tone, or from a 
combination of the two.
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increases In vascular tone, unless 
accompanied by appreciable reduction in 
cardiac output, result inevitably in elevation 
of the systemic blood pressure. Such abnormal 
elevations form a common clinical feature of 
renal, suprarenal, and intracranial disease.
Two clinical types of hypertension are 
discernible ; (I) primary or essential hypertension, 
and (2) hypertension secondary to a known 
pathological condition. Therefore, the two 
forms of hypertension that will be encountered 
in the present inquiry, chronic or essential 
hypertension and hypertensive toxaemia of 
pregnancy, differ in aetiology as well as in 
clinical course.
Essential hypertension is characterised 
in its early stages by an increase in peripheral 
resistance due to an exaggeration of arteriolar 
tone. Thus, in its initial phase, the blood 
pressure of chronic hypertension is subject to 
considerable fluctuation.
Once established, however, the abnormally
15
raised arterial pressure becomes stabilised 
and maintains its height during rest and whilst 
under sedation. At this stage of development, 
thickening of the walls and reduction in calibre 
of the smaller blood vessels Is apparent, the 
left ventricle undergoes hypertrophy, and renal 
function is impaired.
It follows that, whilst angiospasm is 
responsible for the increase in peripheral 
resistance In early chronic hypertension, 
subsequent alterations in the walls of the 
arterioles establish that increased resistance 
as an irreversible feature of the disease. It 
will be seen from later discussion that this 
differentiation between early and established 
chronic hypertension may be of some practical 
Importance in determining the reaction of the 
patient to the intravenous administration of 
Ergometrine.
Arteriolar spasm is an essential feature 
of pre-eclamptic toxaemia of pregnancy (Addis, 
1937 ; Mussey, Hunt & Sluder, 1945 ; %itacre.
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Loeb & Chin, 1947). Whether the enhanced 
arteriolar tone Is the basic cause of pre- 
eclampsia, as claimed by Mongert. Jennett 
& Brown (1949), or simply a secondary 
manifestation of the disease, is still open 
to considerable argument. The facts remain 
that it exists, that by virtue of the resultant 
increase in peripheral resistance it produces 
hypertension, and that it is a menace to the 
gravid patient in terms of morbidity and 
mortality, both maternal and foetal.
This thesis purposes to demonstrate the 
occurrence of a significant hypertensive response 
when the normally weak and usually ineffectual 
vasoGonstrie tor, Ergometrine, is administered 
to patients with increased arteriolar tone, in 
particular women suffering from toxaemia of 
pregnancy.
Some observations on the nature of the 
angiospasticity of pre-eclampsia are therefore 
relevant.
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a n g i o s p a s m IN PRE-EGLAMFSIA.
It is widely accepted that vaaoapaam la 
poaslbly the moat important single disorder 
of physiology in patients suffering from 
pre-eclampsia. This concept, first elaborated 
by Volhard (1918), la substantia ted by the 
observationa of several investigators, although 
the debate as to whether It is the primary or a 
secondary factor of the condition persists.
Evidence of arteriolar spasm is seen in 
the neil-beds where the resistance résulta in a 
degree of circulatory stasis (iitnselmann, 1924). 
Spasm of the retinal arterioles, too, is a 
fairly constant feature of pre-eclampsia and 
eclampsia (wagoner, 1933 ; HaHum, 1936 ;
Wagener & llelth, 1939) and in this site, spastic 
arteriolar contraction can some times be seen. In 
the untreated patient, to proceed to sclerotic 
changes in the walls of these same vessels.
This latter degenerative change is 
reputed to be an ischaemic phenomenon and to 
result from corapreaaion,of the vaaa vasorum
18
by th© continual spasm of the arteriolar wall.
Interfereuü© with the blood supply to 
the kidney oauaas proteinuria and the 
oocurreno© of this urinary abnormality is 
taken as part evidence that the increase in 
arteriolar tone, seen throughout the general 
Glrculation, affects the kidney also.
In an attempt to elucidate the 
compiexities of the haemodynamlc upset in 
acute toxaemia, several workers have exploited 
the activity of tetraethylammonlum chloride 
(Garber et al., 1950 ; Assail et al., 1952). 
The chief function of this compound Is to 
produce blockade of the autonomic ganglia, 
sympathetic and parasympathetic, so that 
isolation of the peripheral vascular tree 
from its neurogenic influences occurs. Under 
the blocking influence of tetraethylammonlum 
chloride, therefore, the blood pressure is 
maintained solely by the action of circulating 
pressor substances on the walls of the blood 
vessels. Wlien derived of Its extrinsic nerve
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supply in this manner^ the tone of the 
arterioles decreases and so in normal non- 
pre^inant subjects and in normotensive pregnant 
women a substantial fall in blood pressure is 
the rule. The administration of tetraethylammonium 
chloride to pre^eclamptic patients^ however, 
produces a much smaller depression of the level 
of blood pressure. This finding, is taken as 
evidence that some humoral mechanism is 
responsible, at least in part, for the 
angiospasm and hypertension of pre-eclampsla•
20
VASOCOÜS'i'RIGïOR EFFECT OP
ERQOMEÎRIWl.
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VASOGOhSTHIGTOH EFFECT OF ERGOmTRINE.
A . EXPERIMEixTAL EVIDENCE.
The year 1935 heralded a new era in the 
praotloe of obstetrics. The isolation of a 
new alkaloid of er^ot in that year by four 
i^roups of investigators, working Independently, 
altered the prognosis of childbearing for a 
countless number of women. Dudley and Molr 
(1935) gave the first detailed description of 
the method of isolation of the nevii alkaloid in 
its crystalline form, together with an account 
of its physical oharacteriotics and chemical 
properties. They suggested that their new 
compound should be called “Ergom©trine.
Later In the same year, similar publications 
came from the laboratories of Thompson (1935), 
Stoll and Burckhardt (1935), and Davis, Adair, 
Chon and Swanson (1935), relating to compounds 
named "erg os to trine", "©X’gobasine", and 
"ergotocin" respectively. After an exchange of 
samples of their compounds, it became clear to
22
the members of all four research teams that 
ergometrin©, ergostetrlne, ergobasine and 
©rgotooln were one and the same substance.
Being derived from a fungus v/hose history 
in the production of vascular damage and 
gangrene was notorious, it was obviously 
desirable to determine whether the action of 
the new oxytocic principle was to be obtained 
at the expense of the circulatoi^ y hasards associated 
v/ith the crude preparations of ergot. As a 
result, the four papers describing the isolation 
of Ergometrine in its crystalline form, were 
soon followed by accounts of the vasoconstrictor 
effects of the substance under experimental 
conditions.
Two series of optically active, isomeric 
alkaloids are obtainable from ergot, all 
derivatives of lysergic acid. The optical 
isomerism results from the presence in the 
lysergic acid portion of the molecule of an 
asymmetric carbon atom. The naturally occurring
23
alkaloids of ergot, including Ergometrine, are 
laevorotatory and only such laevorotatory forms 
are active pharmacologically.
If these naturally-occurring laevorotatory 
alkaloids are now considered on a basis of 
pharmacological activity, two distinct groups 
are discernible. The first group contains 
alkaloids which depress central vasomotor 
reflexes and exhibit a powerful blocking action 
of the pressor effects on sympathetic nerve 
stimulation. The second group, which includes
B.rgometrine, consists of alkaloids of lower 
molecular weight, which have little blocking 
activity.
Direct stimulation of the smooth muscle 
of blood vessels, however, is a form of 
pharmacological activity common to both groups 
of laevorotatory substances. This property 
was demonstrated by Brown and Dale (1936) in a 
study of the effects of intravenous Injections 
of Ergoiiietrine in anaesthetized rabbits and
24
spinal cat preparations* The hypertension that 
resulted in both animals was compared with the 
pressor action of two alkaloids of higher 
molecular weight, ergOtoxine and ergotamine, 
and It was found that,in the intact rabbit, the 
vasoconstrictor action of Ergometrine was greater, 
but in the spinal cat less marked, than the effect 
of these two compounds#
There followed this study a number of 
experimental reports whose evidence was, on 
occasions, conflicting and contradictory, for 
reasons that include the use of experimental 
animals of differing species, and the employment 
of anaesthetics and narcotic agents now known to 
be powerful ganglionic blockers, or otherwise 
depressants of the vasoconstrictor mechanism.
Thompson (1937), in a comparison of the 
pharmacological syndromes of Ergometrine and 
the ergotoxine group of alkaloids, obtained 
only a feeble pressor response when Ergometrine 
was administered intravenously to cats under 
chlorbutanol narcosis. The same worker obtained
25
but a slight rise in the blood pressure levels 
of dogs under thlobarbiturate anaesthesia.
In both his series of experiments, therefore, 
Thompson was employing vasodilator agents as 
the only form of anaesthesia. Moreover, the 
thlobarbiturate used in the second group of 
animals is now known to reduce the adrenergic 
blocking potency of the ergot alkaloids. In 
other words, the narcosis under which the 
animal experiments were conducted, interfered 
with the action of Ergom©trine at a ganglionic 
level and by direct action on the arteriolar 
walls. The inference is, therefore, that the 
pressor response obtained by Thompson was 
greatly modified.
In vagotomized dogS, under chloralose 
anaesthesia with intermittent positive-pressure 
ventilation of the lungs, Ergornetrine exerts a 
powerful pressor effect (liamet, 1935). A 
point of particular interest^that may also be 
of considerable practical significance In
patients with pre-eclampsia and women with
26
concealed accidental haemorrhage, is the finding 
of this investigator that Ergometrine causes renal 
vasoconstriction in the vagotomized experimental 
animal.
Repeated doses of Ergometrine produce a 
progressively decreasing vasoconstrictor response 
(Brown à Dale, 1935), a finding characteristic of 
all the alkaloids of ergot.
The vasoconstrictor action on isolated 
vessels has also been observed. Ergometrine 
constricts the leg vessels of the frog (Davis et 
al., 1935) and the ear vessels of the rabbit 
(Rothlin, 1935 $ Savin!, 1956).
Modification of the vasoconstrictor activity 
of the ergot alkaloids by some methods of 
narcosis has been noted already. There follows 
an account of papers whose evidence seems to 
conflict with the vasotonic actions already 
described. All animals, however, were 
anaesthetized by agents which would interfere 
greatly with the pharmacological activity of 
the drug under investigation.
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hothlln (1935) Investigated the action 
of Ergome trine in cate and dogs, and was unable 
to evoke hypertension in either. This 
observation, although not appreciated at the 
time, was due to the fact that the cats were 
studied under ether, chloralose, and 
thlobarbiturate anaesthesia, while the dOgS 
were anaesthetized with ether. It was Brown 
and Dale (1935) who pointed out that anaesthesia, 
possibly accompanied by respiratory depression 
and paralysis of the vasomotor centre, accounted 
for the absence of a pressor response or even 
the production of a vasodepressor effect. This 
latter experimental observation has been 
translated Into clinical terms in the current 
study of the vasopressor effect of Ergometrine 
in parturient women, and it will be demonstrated 
later how the systemic effects of Ergom©trine 
may he obviated by employing certain anaesthetic 
agents.
Despite the fact that Ergometrine has been 
in clinical use for a period of twenty-five years,
28
almost ail the medical publications relating 
to its pharmacological activity have dealt 
with the oxytocic property of the drug. The 
ability of Ergometrine to control post partum 
bleeding has won for this agent universal and 
almost routine adoption in the care of the 
parturient woman, yet comparatively little 
study has been devoted to its systemic effects. 
The presence of any appreciable vasopressor 
activity in clinical dosage is denied by 
several standard works (Micks, 1950 ; Smith, 
1938 ; food « Smith & 5tewart, 1962) despite 
the provision of adequate experimental evidence 
to suggest its possible existence. At this 
Juncture, a critical evaluation of the few 
relevant clinical reports is indicated.
B. SYSTEMIC EFFECTS Oh PaRTURlEhT f O m m .
Dieckmann, Forman and Philips (1950), 
perturbed by the dogmatic statement in several
textbooks of pharmacology that Ergometrine in
29
therapeutic doses exerts no systemic effects, 
published a report of the symptomatology of 
thirty-seven patients who had received 0.4 mg.
Ergometrine intravenously. This interesting 
paper appears to have escaped the notice of a 
few subsequent writers who still deny that this 
oxytocic agent can produce slde-effects of 
appreciable severity (Wood-Smith & Stewart, 1962).
The symptoms described by the patients and 
their respective incidence were as follows ;-
abdominal cramp 67$ (due to uterine contraction)
dizziness 19$
nausea 14$ (vomiting in 1 patient)
headache 14$
Of twelve women in whom the course of the blood 
pressure was followed, seven |>8$) had a rise in 
systolic or diastolic level of at least 10 mm.Eg. 
Unfortunately, no record is given of the resting 
pressures of the patients in whom a pressor 
response was evoked.
Schade (1951), in a comparative clinical 
study of the vasomotor properties of Ergometrine
30
and Methyl Ergometrine, observed the changes in 
blood pressure of four hundred parturient women. 
Half that number received 0.2 mg. Ergometrine 
and the other half 0.2 mg* Methyl Ergometrine 
by intravenous injection. A pressure of 
140/80 mm.Hg was accepted as upper limit of 
normal and 20 mm.Hg taken to be a significant 
elevation. Ten hypertensive patients presented 
in the series and in six of these, Ergometrine 
evoked a significant rise in blood pressure.
The results of Schade*s investigation and 
the conclusions drawn from them cannot be 
accepted without criticism. Firstly, 74$ of 
the women in the Ergometrine series were 
delivered under spinal analgesia, an effective 
means of reducing blood pressure, depending on 
the level reached by the analgesic solution in 
the subarachnoid space. neither the type of 
spinal analgesia nor the level attained is 
recorded. Secondly, 25.5$ of the remaining 
women in the Ergometrine series were 
anaesthetized with nitrous oxide, oxygen and
31
di-ethyl ether, and since it la Intended to 
show later how this very anaesthetic method 
is an effective means of counteracting the 
vasopressor activity of Ergometrine, two 
observations are presented that tend to 
invalidate the results. On© interesting part 
of this report, however, to vfhieh reference 
will be maae later, describes the occurrence 
of convulsions in the puerperium in a patient 
delivered of twins and to whom Brgometrin© had 
been administered# In passing. It Is to be 
noted that the intravenous dose of Ergometrine 
employed in SchadeInvestigation was less 
than half the standard Intravenous dose used in 
many obstetric units in Great Britain.
In the following year, Hamilton, Biggins 
and Alsop, in a comparative study of naturally 
occurring and synthetic oxytocic agents, 
reported that in 166 patients who received 
0.2 mg. Ergometrine intravenously, a significant 
hypertensive response (i.e. at least 20 mm.Hg.) 
was obtained in 12 - 15$. Bone of the women
32
in this series bad evidence of toxaemia of 
pregnancy. All were delivered under general 
anaesthesia, some with nitrous oxide and oxygen, 
others with nitrous oxide, oxygen and di-ethyl 
ether. These differences in technique 
introduce an undesirable variant to the 
investigation, since pressor responses will 
be evident under nitrous oxide anaesthesia with 
adequate oxygenation, but inhibited by ether 
or by nitroua oxide with sub-oxygenation. 
Nevertheless, the authors concluded that 
"elevations in blood pressure resulting from 
the use of ergonovlne (Ergometrine) ...... in
the third stage of labour can be effectively 
reduced by the judicious use of premedication 
and anaesthesia". A further and interesting 
observation made by these three investigators 
was a dramatic hypertensive response occurring 
in two women who received 0.2 mg. Ergometrine 
intravenously and 1 cc. ^Pltocln' into the 
uterine muscle simultaneously.
Another large ano more recent study Is that
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of MoGlnty (1956). Of two hundred patients 
In this series who received oxytocic drugs 
as part of the management of the third stage 
of labour, fifty were given 0.2 mg.
Brgom©trine maleat© intravenously, and of 
this latter number, ten out of thirty-eight 
normotensive and four out of twelve hypertensive 
patients had a significant rise in systolic 
blood pressure. as in the series of Schade 
and of Hamilton and his associates, 20 mm.Hg . 
was considered by MoOlnty to be an acceptably 
significant elevation.
It is worthy of note that in McGlnty *s 
series all patients had vaginal deliveries under 
pudendal block analgesia, the latter being 
achieved with an analgesic solution containing 
1 : 100,000 adrenaline. The elevation of 
systolic blood pressure in the non-toxaemlo 
women was noted to be of a transient nature, in 
which case the critical observer must assume 
that the vasopressor agent contained in the 
analgesic solution had an undesirable generalised
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influence on the vascular bed, so tending to 
invalidate the results of an otherwise well 
conducted study.
It is evident from consideration of the 
foregoing reports that there is need for a 
critical clinical study of the vasopressor 
activity of Ergometrine in parturient women. 
It is believed that under modern conditions 
of anaesthesia, a true index of the 
vasoconstrictor activity of this drug is 
obtainable, and to this end the investigation 
about to be described was instituted.
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METHOD OF STUDÏ.
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iVxbTliÛD QI* 6TUPI.
A. BXTRQUb OXXDE, Qa IQEB, MUaCLL RELaXa BT SERIES.
In the first part of this investigation, a 
study was made of 256 patients requiring general 
anaesthesia for delivery by obstetric forceps or 
Caesarean Section, and for the purposes of the 
inquiry, the anaesthetic technique employed was 
standard.
Pre-anaesthetic medication consisted of 
0.6 rng. atropine sulphate only. Following 
intravenous induction of anaesthesia with 
200 - 250 mg. thiopentone sodium, succinylcholine 
60-70 mg. was given to allow immediate endotracheal 
intubation. Thereafter, intermittent positive- 
preasure insufflation of the lungs was carried 
out with nitrous oxide gas and oxygen, 
succinylcholine being repeated to maintain apnoea 
and muscular flaccidity. Increments of 
succinylcholine were of the order of 20 mg., not 
only because of the danger of cardiac irregularity 
and standstill with larger amounts, but also 
because previous experience had shown that
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increments in excess of 20 mg. produced spikes 
of temporary rise in arterial blood pressure.
The dose of Ergometrine maleate was 0.6 mg. 
in all patients. This was usually administered 
by intravenous injection at the time of delivery 
of the anterior shoulder of the baby, but in 
21 vi/omen, injection of the oxytocic agent was 
delayed until delivery of the placenta had 
occurred and uterine contraction and retraction 
established. This latter group afforded an 
opportunity to study any alterations in arterial 
pressure following delivery that might not be 
attributable to Ergometrine.
In recording the systemic blood pressures 
the auscultatory method was employed in order to 
obtain diastolic as well as systolic levels.
The basal or resting blood pressure was taken 
as that pressure recorded on admission, in the 
case of emergency procedures, or as that found 
during ante-natal examination, in the case of 
elective operations. D©termination of this 
basal pressure was made with considerable care
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since this reading afforded the only reasonable 
means of segregating the patients into groups, 
the pressor values obtained during established 
labour often bearing little or no relationship 
to the true resting state of the peripheral 
vascular bed.
Early in the investigation, it was found 
that patients exhibiting a vasopressor response 
did so within two minutes and that after the 
third minute no further elevation occurred.
AS a result, only the rise in systemic blood 
pressure three minutes after administration 
of Ergometrine is recorded in Tables 1 - 111, 
although in all patients the readings were 
charted throughout operation.
All the women studied and whose pressure 
changes are recorded hereafter were anaesthetized 
by the author personally. The only cases 
excluded from the series were patients who 
required active resuscitation to render them fit 
for operation and those whose rapid deterioration 
due to operative haemorrhage rendered them
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valueless as far as this study was corioerned.
After a study of the series of patients 
anaesthetized by the thlobarbiturate, muscle 
relaxant, nitrous oxide and oxygen technique, 
it was envisaged that by employing vasodilator 
techniques of anaesthesia, the pressor effect 
of Ergometrine in toxaemlc patients might be 
modified. Three further anaesthetic sequences 
were used in selected patients, known to be 
suffering from established pre-eclamptic 
toxaemia of pregnancy. These sequences were : -
(1) nitrous oxide, oxygen and halothane 
in a semi-closed system,
(B) nitrous oxide, oxygen and ether in 
a semi-closed circuit, and 
(3) cyclopropane and oxygen in a closed 
circuit.
B. Ha LQTBaNE BEEXES.
The behaviour under halothane anaesthesia 
of eight known pre-eclamptio patients was 
observed. Premedioatlon consisted of atropine
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sulphate 0.6 mg. only and was therefore devoid 
of drugs known to cause vaaodepression.
Thiopentone sodium 250 mg. was given 
intravenously to produce unooiisciouaness, 
followed by succinylcholine 70 mg. to allow 
easy and rapid Intubation of the trachea.
Following isolation of the respiratory tract, 
the lung8 were inflated rhythmically with 
nitrous oxide and oxygen. Halothane 1.0$ was 
added to the gaseous mixture from a calibrated 
and temperature-compensated vaporizer. In all 
eight women the period of respiratory paralysis 
lasted only a few minutes and all were breathing 
spontaneously at the time of delivery and of 
administration of Ergometrin© 0.5 mg. intravenously.
The blood pressure readings ware recorded 
by the auscultatory method and at the same times 
as in the previous series. Deep halothane 
narcosis was not sought on any occasion and^ 
despite reports that uterine relaxation v/ith 
this anaesthetic agent may cause abnormal 
loss of blood (MaoKay 1957 ; Russell 1958 ;
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Albert et al, 1959 ; Crawford 1962), bleeding 
was not excessive and the results were not 
therefore influenced by marked alterations in 
circulating blood volume.
ETHBB SERIES.
Since the administration of ether 
anaesthesia is known to cause peripheral 
vasodilatation, it was next decided to explore 
the possibility of protecting toxaemic women 
froui the circulatory effects of Ergomatrine by 
aaministaring this anaesthetic agent to a 
series of six pre-eclamptic patients.
Atropine was given as pre-anaesthetic 
medication as before, and endotracheal anaesthesia 
attained by induction with thiopentone sodium and 
succinylcholine in the dosage employed in the 
above series. Intermittent positlve-pressure 
insufflation of the lungs was then instituted 
with nitrous oxide and oxygen, and di-ethyl 
ether vapour added to the mixture during the 
period of apnoea. The gases and vapour were
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delivered to the patients via a Magill semi- 
closed apparatus. Once spontaneous 
respiration had been re-established, a plan© 
of moderate surgical anaesthesia was sought 
before delivery of the baby occurred. Thus 
all six women were breathing spontaneously and 
were at a comparable level of anaesthesia when 
0.5 mg. Ere>ometrine was administered 
intravenously.
Alterations in blood pressure were noted 
ano in particular chan^^es three minutes after 
injection of the oxytocic agent.
Patient number 6 in this series (see 
Table x), the most severely hypertensive of 
the ^roup, had an eclamptic convulsion 
immediately prior to induction of anaesthesia.
D. CyCLOPROPAKE SERIES.
The vasodilator effect of cyclopropane 
and its influence on the Ergometrine effect 
were investigated in two ways ; firstly to a 
group of five pre-eclamptic women cyclopropane
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and oxygen virere given as the sole agents from 
a Boyle mark 11 closed circuit apparatus in 
order to determine what decree of protection 
might be afforded against the vasoconstrictor 
activity of Ergometrine, and secondly, in two 
pre-eclamptic women in whom Ergometrine had 
evoked a pressor response, the effect of 
cyclopropane was observed.
The provision of anaesthesia for assisted 
breech delivery presents a problem that is 
peculiar to this obstetric manjê'p^ lxvre. In this 
type of delivery, the voluntary efforts of the 
patient are employed to effect delivery of the 
breech as far as the scapulae. The head is 
then delivered with the mother anaesthetized 
so that moulding and re-expansion of the foetal 
head might be controlled and the danger of 
intracranial haemorrhage be eliminated or 
reduced. Such a mode of delivery calls for 
induction of anaesthesia with the patient in 
the lithotomy position, in violation of the 
laws of obstetric anaesthesia.
44
From the point of view of the present 
Inquir;^ ,^ inhalation of cyclopropane and oxygen 
provides a convenient method of anaesthesia 
since this hydrocarbon produces a relatively 
pleasant and rapid induction of unconsciousness, 
li^aht anaesthesia for delivery of the foetal 
head with considerable maternal safety and 
marked dilatation of the peripheral vascular 
bed.
The vasodilator effect of cyclopropane is 
maximal under light anaesthesia (Kitchen et al., 
1955) ; thus in all five toxaemic patients 
anaesthetized in this manner for assisted breech 
delivery, a considerable degree of vasodilator 
activity was present when hrgometrine 0,5 mg. 
was given intravenously.
During anaesthesia with nitrous oxide, 
oxygen and sucoinylchioline, two patients suffering 
from pre-eclampsia produced an elevation of blood 
pressure after intravenous hrgometrine. 
Cyclopropane was added to the gaseous mixture and 
the alterations in pressure recorded.
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£. PIlTHIDIhK SFRIES.
It is common practice to enhance per-operative 
maternal analgesia by administration of 
intravenous pethidine, but since this drug is a 
profound depressant of the respiratory centres, 
it is proper policy to withhold it until delivery 
of the baby has been executed*
AS pethidine is reputed to have a papaverine- 
IIko effect on the smooth muscle of the smaller 
blood vessels (Gunn, 1948), it seemed logical to 
determine whether or not its administration was 
effective In modifying the rise In blood pressure 
produced by hrgometrine *
Pethidine hydrochloride 50 mg* was given by 
intravenous Injection to thirteen women in whom 
a pressor response had been evoked by the ergot 
alkaloid and the systemic blood pressure 
observed carefully.
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R E S U L T S .
47
KESULTS.
A. TROUS OXIDE, OXYGm, BELhXhin SERIES*
On account of the large number of patients 
Investigated in this series, the detailed readings 
of blood pressure, from which Tables I, II, and 
III are compiled, are to be found in Appendices 
A, B, and G respectively *
In the 256 patients to whom Ergometrine was 
administered, the arterial blood pressure was 
recorded at three specific stages in the 
procedure i (X) preoperatlvely or on admission,
(2) at the moment of intravenous injection of 
the drug, and (3) three minutes after the 
injection*
For the purpose of analysis of the results, 
the cases were arranged in ascending order of 
basal diastolic pressure.
From a statistical viewpoint, classification 
of the cases studied is important and the 
establishment of a group of normotensive 
individuals necessary* Opinion as to the
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acceptable upper limit of normal blood pressure 
in pregnancy varies and different authors have 
set their own standards of normality* Browne 
(1946) considered that any reading greater 
than 120/80 mm*Mg *, should be regarded as 
abnormal, whereas de Lee and Greenhill (1948) 
and Mcllroy (1936) define abnormal arterial 
pressure in pregnancy as being one greater than 
130/90 mm.hg* For the purpose of this 
investigation, the author has accepted a 
diastolic blood pressure of less than 90 mm*Hg*, 
as being normal. Table X and Appendix A contain 
the details of patients of this supposedly 
normotensive group* The remaining women were 
placed in two further groups, depending on 
whether the resting diastolic pressure was 
between 90 and 99 mm.Eg *, or greater than 
100 mm * . Details of the second group are
contained in Table II and -appendix B, and of 
the third in Table III and Appendix C*
169 women presented in the normotensive 
category (Table I). Of these, eight showed
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an elevation of blood pressure of at least 
SO mm.Hg., following the intravenous injection 
of Ergometrine* Seven twin pregnancies occurred
in this group and one is compelled to draw 
attention to the fact that of the eight 
normotensive patients who showed a significant 
response (4*7^), plural pregnancy accounted for 
five* One other of the eight had oedema and 
albuminuria, despite a basal systemic pressure 
of 120/80 mm*Mg*
The second category (Table II) Is composed 
of the 53 patients with basal preoperative 
diastolic pressures of between 90 and 99 m m * % , , 
and might be considered to be a mixed group 
of normotensive and pre-eclamptic individuals* 
kVithin this range of diastolic blood 
pressure there was a marked increase in the 
percentage of oases showing an elevation of 
20 nmuhg*, seven women (13*2^) exhibiting a 
response of that order.
Of women in the second group who failed 
to show a marked elevation, two suffered from
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diabetes, two had renal disease, and three 
carried a preoperative diagnosis of chronic 
hypertension. as one might expect, the patients 
with essential hypertension were of the higher 
86)0 group, two being thirty-eight and one forty 
years of age. Two patients, both with clinical 
features of severe toxaemia of pregnancy, 
sustained a significant fall in blood pressure 
after injection of the ergot alkaloid.
Cases with a diastolic blood pressure of 
at least 100 mm.Eg., are detailed in Table III 
and number thirty-one of the total. Intravenous 
injection of Ergometrine evoked an elevation of 
blood pressure of at least 20 mm.Hg., in fifteen 
members of this group (48.4%).
Of the women who retained their pre- 
ergometrine level of systemic pressure, one, 
who had had an eclamptic seizure and who 
subsequently gave birth to twins, was under 
moderately deep tribromethanol narcosis at the 
time of induction of surgical anaesthesia. 
Intravenous injection of the alkaloid caused no
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rise in her arterial blood pressure.
The blood pressure fell in one severely 
toxaemic patient from 170/180 mm.lg., to 
150/l06 mm.Hg., and this drop coincided with 
delivery and injection of the oxytocic agent.
It is worthy of note that only eleven patients 
within this range of basal blood pressure 
showed a response of leas than 10 mm.Hg.
Eight of these suffered from chronic hypertensive 
cardiovascular disease and were, moreover, the 
oldest women in the group, one being aged 36, 
tv/o aged 37, two aged 39, one 42 and another 
44 years.
The last five patients of the series, all 
with a resting diastolic pressure of more than 
110 mm.Hg., showed no appreciable alteration 
in the pre-ergometrine level despite the obvious 
general increase in incidence of pressor response 
with height of basal pressure. Thus there is 
a tendency for the vasoconstrictor response to 
Brgometrine to increase with height of resting 
blood pressure up to the region of 110 mm.Hg.,
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TABLB IV.
VASOPEESSOH EFFECT OF EEGOMETEIME - 
2B0IDB&0E OF 8IGBIFI0ANT ELEVATION COMPARED WITB 
LEVEL OF RESTING DIASTOLIC BLOOD PRESSURE*
Ifumbor of patlonte 
Eia© of ^  20 mm#% in
Bafial diaotollo Llood pressure of
90 mm*%,
169. 
4.7^
90 «* 99
13.2^
100 - 103 tnm,%
19
52*6%
^110 mm,%#
12#
41.7^
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diastolic ; thereafter, the frequency of 
response in this series of patients decreases.
This feature is evident from reference to 
Table IV.
s t a t i s t i c a l iuuL^axa.
The decrease in frequency of the vasopressor 
response In patients with a diastolic pressure 
of mere than 110 mnuHg., results from the fact 
that non© of the patients with established 
chronic hypertensive cardiovascular disease 
exhibited any appreciable alteration in pressure 
after delivery. It is obvious, therefore, on 
elinioal grounds alone, that this group interferes 
with the general trend of increasing incidence of 
vaaoconstrictor response with ascending height of 
basal blood pressure, so that before the three 
groups of patients in Tables I, II, and III will 
bear statistical comparison, all oases of 
chronic hypertension must be excluded from the 
entire series.
Furthermore, it has been noted that the
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TABLE Y.
COMPARISON OF PRESSOR RESPONSE IN THREE GROUPS OP WOMEN UNDER 
NITROUS OXIDE, OXYGEN, RELAXANT ANAESTHESIA,
(Patlonts with twin prsgnaaoy & ohronlo liypertenslon ezoludod)
lUoe in Systolic BP Nun:
DBF < 90 mm#
iber of Patleata « 
DBP ?0 - 99 mm. DBP ^  100 mm.
1 0 -*» 19 159 (98,1^ ) 42 (87,5^) 6 (28.6#) 207
1 ^ 20 3 (1.9#) 6 (12.5S&) 15 (71.4#) 24
162 48 21 231
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Incidence of elevation of blood pressure after 
intravenous injection of LrgOrnetrine is much 
higher in normotensive twin pregnancy than in 
the single pregnancies occurring in the 
normotensive category* All cases of twin 
pregnancy are therefore excluded also from the 
correctea fable V.
It has been suspected clinically from the 
results of Tables I - III that in the absence 
of chronic hypertension, the greater the basal 
diastolic blood pressure, the more likely will 
hrgometrine evoke a vasoconstrictor response.
Also, it appears that the greater the resting 
pressure, the more severe the individual elevation. 
In short, the vasopressor response to Intravenous 
hrgo me trine increases in incidence and degree with 
basal diastolic blood pressure.
That this clinical suspicion is not without 
reason has been borne out by analysis of the 
correctea figures for the series (lable V).
o
By employing the X test it was shown that the 
difference in frequency of marked pressor
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activity (i.e. a rise in systolic pressure of 
at least 20 mm.Eg.) between patients of 
Table I and Table IX is significant and between 
patients of Table II and Table III more so, 
all women with chronic hypertension or twin 
pregnancy excluded. The actual values obtained 
for X were 7.8 (?<0.01) and 21.3 (P<0.001) 
respectively.
FIthdSOK hFghOT OF M i Q O m m i m  lU TvVIE PBEGNAEGI.
Ten twin pregnancies occurred in the course 
of the investigation. Five of seven, falling 
into the normotensive category showed a significant 
elevation of blood pressure, one a rise of 
12/6 mm.Hg., and the seventh no alteration from 
the pre-ergom©trin© level. Of the three 
hypertensive mothers, a significant response was 
elicited in one, a rise of 14/10 rmii.Hg., in the 
second, and no response in the third who was under 
the narcotic influence of tribromethanol.
Thus the incidence of appreciable 
vasocoaatrietion following Ergometrine in
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TABLE VI.
RESPONSE IN NORMOTENSIVE TWIN PREGNANCY OOMPARED 
WITH THAT IN NOmOTBNSIVE SINGLE PREGNANCY,
Rise in BP, mm*Hg* NumLer of T\?in NumLer of Single
PrognanoloB Pregnancieo
0 ~ 19 2 (28.6‘/) 159 (98.#)
20 «. 5 (71.#) 3 (28.6^ )
TOTALS 7. 162.
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uncomplicated twin pregnancy is much higher 
than in other normotensive women, as is shown 
in Table VI, The statistical Bi^nifioance of 
this variation of response in normotensive 
women was calculated from Table VI thusj*»
X® - ( 159x 5 - 2x3 - 169
161x8x 162x9
, 8 3,878,182.28  
l,460,èé8
» 8 7 .9 (P<0 .0 8 )
2
The X test, therefore, shows that there is a 
significant difference between normotensive 
twin pregnancy and normotensive single pregnancy 
with respect to incidence of Krgometrine effect#
FhhobQK hl'FhCl 01 hhOOMhTIHhh XiM GliiiQhXG 
hXFhhThh^XVh büKDXOVübUyL/iK DX6hA8E#
Essential hypertension was diagnosed 
preoperatlvely in twelve women treated in the 
course of this inquiry# Despite the high resting 
diastolic blood pressures of these patients, none 
shared in the general tendency of hypertensive 
women to exhibit a significant elevation in
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TÆBLE VII
RESPOIISE TO IMTEAVBHOtrS EEGOÎÆETEIHK IK 
PATIENTS WITH OHEOKIO HYPERTENSION.
Rise in Systolia Basai diastolic blood procsuro, mm,% .
BPÿ mra*Hg, 90 - 99 ^  100
0. 2, 2.
1 «» 9* 1. 9*
10 - 19. 1* 1.
? 20# 0, 0.
4# 8,
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pressure following injection of Ergometrine 
(Table VII}# This difference in response 
in the two hypertensive groups, toxaemic and 
chronic, is significant*
apart from patients who presented ’with 
a well-defined picture of chronic hypertension, 
there existed in the series, without doubt, 
patients with minor degrees of hypertensive 
cardiovascular disease, perhaps co-existing 
with hypertensive toxaemia#
INFLUENCE OF UTERINE COhTRACTIQh aHD 
RETRACTION Oii m  TERN Ah BLOOD PRESSURE#
It is a popular belief that uterine 
contraction and retraction occurring after 
delivery of the placenta Increase the circulating 
blood volume to such a degree that a rise in 
systemic blood pressure might be expected# Two 
features of the current study contest this 
argument strongly# Firstly, a great many 
patients in the normotensive category showed 
no difference between their pre « and post -
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TABLE VIII.
RECORD OP BLOOD PRESSURE IN 21 PATIENTS TO SHOW
(a) proBsure changes following delivery when Ergometrine is withheld,
(b) any subséquent alteration due to pressor activity of Ergometrine#
Basal BP 
mnuHg*
DP at
delivery
mm.Hg,
DP at time 
of I.V, Injection
mm+Hg*
Alteration 
in BP.
mm.Hg,
Delivery-
Injection
Interval
mine.
Rise in BP 
after I,V, 
Ergometrine
100/65 140/100 140/100 0/0 3# 0/0
100/65 150/104 146/104 -4/0 7. 0/0
115/70 142/90 142/98 0/0 5* 0/0
120/70 146/86 140/84 *•6 /—2 6, 0/4
120/80 150/104 146/104 -4/0 3. 6/4
120/80 140/96 140/96 0/0 6p 0/0
120/84 164/120 164/120 0/0 3$ 0/0
120/84 144/108 142/108 -2/0 3# 4/8
120/85 132/94 134/94 +2/0 3# 4/4
122/92 108/84 112/86 +4/+2 9. 6/0
124/96 144/90 144/92 0/+2 3. 0/2
126/90 126/90 130/90 +4/0 3. 10/8
130/80 120/76 120/80 0/+4 3 10/4
130/85 140/92 140/94 0/+2 5. 10/4
130/90 120/86 120/88 0/+2 3. 0/2
140/90 132/90 130/90 -2/0 3. 10/10
140/96 164/108 164/110 O/+2 6, 16/6
140/100 148/96 148/98 O/+2 5* 18/10
140/100 140/100 140/100 0/0 3» 30/22
144/116 184/132 186/134 + 2/+2 3, 0/0
156/90 140/84 142/84 +2/0 6, 10/4
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Ergometrine levais of blood pressure.
Secondly, to exclude this contention completely, 
the administration of Ergometrine to twenty-one 
women was delayed for some time after delivery 
of the placenta and the demonstration of good 
uterine retraction. Any alterations In 
pressure occurring in the period between 
delivery of the baby and subsequent administration 
of Ergometrine were recorded and are presented 
in Table VIII. It is clear from the results 
of this delayed injection that uterine contraction 
and retraction alter the systemic blood pressure 
little, if at all. The only alterations in 
pressure are obviously due to the pressor activity 
of the ergOt alkaloid.
DURATION OF PBES30H RESPONSE TO ERGOMETRINE.
The duration of the circulatory response to 
Ergometrine is one of obvious practical importance. 
In women delivered by forceps, no definite 
conclusion could be reached in this respect since 
the procedure terminated in all cases while the
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pressor effect was still maximal. Thereafter, 
the influence of narcotic medication, the amount 
of handling, environmental and bed temperatures, 
and return of voluntary activity combined to 
produce an undecipherable and statistically 
valueless picture.
Greater opportunity for observation of 
this aspect of the study was afforded by the 
oases of Caesarean Section. The average duration 
of this operation, from intubation to v^lthdrawal 
of anaesthesia, is in the region of 45 minutes, 
and no noticeable decline occurs until the 
operation is drawing to a close, i.e. about 
thirty minutes after the actual delivery. Nine 
oases of Caesarean Section, however, during which 
an appreciable rise in blood pressure had occurred, 
lasted over ninety minutes and in each the blood 
pressure had returned to the pre-ergometrine 
level by the end of the procedure. From this 
observation it is concluded that the duration 
of the Ergometrine effect is in the region of 
one hour, the maximal response remaining in
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evidence for thirty minutes.
B. IULQTBaNE SERIES.
In the subsequent series, we shall consider 
patients in whom a preoperative diagnosis of 
pre-eclamptic toxaemia had been established.
The results obtained in these toxaemic patients 
under alternative forms of anaesthesia should be 
examined in the light of the findings of the 
nitrous oxide, oxygen, relaxant series as a 
control. The lack of interference with the 
integrity of the vasoconstrictor mechanism by 
the gas, oxygen aucoinylcholine technique is 
to be stressed in this respect ; this anaesthetic 
sequence probably gives an even better control 
than conscious subjects, in whom such factors as 
exaggerated psychomotor activity and voluntary 
movement associated with spontaneous vaginal 
delivery might give a less true index of the 
behaviour of the systemic blood pressure after 
administration of Ergometrine.
The readings obtained from the eight patients
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BABM3 IX.
PHESSOR BPPEGT OP ER(30MEmKB.
CHANGES IN BLOOD PRESSURE DURING HALOÏEANE AHAESKISSIA.
Ida n%ific at ion 
Number
Age BaeaX BP 
mm.Hg.
BP at time of
1,7, Srgometspine
Rise after 
3 rains, 
mm*%.
I. 28# 140/90 154/114 0/0
2. 28* 150/90 132/94 0/0
3» 30. 160/90 140/94 4/0
4 # 28* 130/94 136/90 4/0
5. 27* 160/98 140/94 0/0
6. 24* 140/100 140/96 4/0
7. 46* 160/108 126/88 12/10
8. 31* 180/130 160/122 12/8
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anaeathetlaed with laltroua oxide, oxygen, and 
halothane are recorded in lable IX in order of 
ascending basal diastolic blood pressure. In 
this Table, both the hypertensive ^^roups examined 
in the previous series are represented.
Krgometrine 0.5 mg. produced a recognisable 
elevation of blood pressure in two severely 
pre-eclamptic women whose respective basal 
pressures were I6Q/IO8 mm.Hg., and 180/130 mm.Hg., 
in each the rise was of the order of 12 mm.
If, as in the previous series, 80 mm., Is 
considered as a significant rise, then in no 
patient unaer halothane anaesthesia did 
hr^^ometrine evoke a si^^nifleant pressor response. 
This result contrasts markedly with the results 
recorded in Table IV.
It is concluded from the foregoing results 
that halothane anaesthesia Inhibits the pressor 
response to intravenous Ergometrine in 
pre-eclamptic women. The statistical significance 
of the results will be considered later.
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TABLE X.
PRESSOR EPPECT OP ERGOMETRIMÏÏ.
OKAHGBS IH BLOOD PRESSURE DURING DI-ETHYL ETHER ANAESTHESIA,
Identification
number.
Age Basal BP 
mra.Hg.
Bp at time of 
I.V* Ergometrlno 
mm.Hg.
Hiae after 
3 mlna.
!♦ 30$ 134/92 124/90 0/0
2. 22. 130/96 134/98 0/0
3* 35. 140/96 124/90 0/0
4* 17. 146/96 150/96 6/0
5. 19. 132/104 126/90 0/0
6, 21. 170/110 164/106 2/4
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ü. D i - m m L  h'ihhk bMiikb .
Di-©thyi ether was employed to provide 
surgical anaesthesia for six cases of delivery 
by obstetric forceps. The two hypertensive 
(groups established in the control series will 
be found to be represented in the records of 
blood pressure Table X. None of the four 
moderately or two severely toxaernic women 
experienced an appreciable alteration in 
systolic pressure. In this group of pre­
eclamptic patients, therefore, ether appeared 
to afford complete protection from the 
vasoconstrictor activity of Ergometrine.
D. CïGLQFKOPa NE SEKlEa.
Part (ii of Table XI records the blood 
pressure readings obtained in the series of 
breech deliveries under cyclopropane ; oxygen 
anaesthesia. The intravenous injection of 
Ergometrine caused no alteration in the systemic 
blood pressure of four of the five subjects 
studied. The elevation In the fourth was of
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TABLE XI.
PRESSOR EFFECT OF EE80METRINE.
CJIAÏTGE3 IN BLOOD PRESSURE DOHIÎIO CY0LOPHÛPABE ANAESTHESIA.
(l) Induction and raaintenanoo of anaesthesia mlth oyolopropane.
Identification
ÎTitinbori Ago*
Basal BP BP at time of 
I.V* iSrgometrine
mm*Eg.
Biae after 
3 mine*
1$ 33* 134/90 144/96 6/4
2# 34* 136/94 130/100 0/0
3# 23. 136/96 126/90 0/0
4« 20. 140/96 126/90 0/0
5# 24. 154/100 140/94 0/0
#1 »;tp,in #!FiW;Wiwi M* V w w niviTywA-w
(2) Induction with thiopentone, euaoinyXoholine^ followed by*
nitrouB oxide and oxygen« Cyclopropane after establishment
of preaaor response#
Identification Age* Basal BP BP at time of Hiae after BP after 10
Humber* mm.Hg* I .Ergome trine, 3 mine* mine * of
mm.Eg, cyclopropane
1# 23* 140/90 126/96 28/4 120/94
2. 31* 140/100 140/100 40/24 150/104
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no significance*
it is shown by Part(2) of the same Table 
that light cyclopropane anaesthesia will, 
moreover, abolish an already established vasopressor 
response produced by the same oxytocic drug.
statistical ANALYSIS €t GROUPS B, C, AND D .
ifT -L- nwTr.iU Mil i,m #i wm rm in mr nrYri - iti i i ri'f"r-r~^i'*fr-   — —-""-"i-TT-T-rrr—    f .    y_.,  
The group of women in Table II, whose basal 
diastolic blood pressure was between 90 and 99 
mm.Eg., is a heterogeneous one, there being 
contained therein normotenslv© individuals, 
chronic hypertensives, and pre-eclamptio patients. 
Thus it would require an exceedIngly large number 
of oases under alternative forms of anaesthesia 
in oztier to establish a significant difference 
in response to Ergometrine,
On the otbei'’ hand, few cases are required 
to establish any difference between groups of 
patients whose basal diastolic blood pressure 
is 100 mm * hg. The patients in the control 
series with hypertension of this order were 
compared with the six grossly hypertensive
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TABLE XII.
RESPONSE TO ERGOMBTRINB IN EYPERTI#SIVE WOMEN - ÏNFLtîMCE OF
MAESTHETIG TECHNIQUE.
(pationts with ohronlo hypertension 
and twin pregnancy excluded)
Gas § oxygen ? 
relaxant.
Gas g oxygen s 
halothane.
Gas g oxygen s 
ether.
Oyolopropane s 
oxygen.
Ho. of patients 71. 8. é* 5t
Incidence of rise 
of ^  20 31.0^ ^ afà*
\
0^ . 0^ .
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TABLE XIII.
PRE8S0H EFFECT OF BRGOIilETRIffl. 
INFLUENCE OP PBTHIBIHE HYDROCHLORIDE 50 mg* INTHAVHNOÜSLT*
Rise in oystollo BP Average drop In BP
following Ergomotrlne, NuiaTber of Patients after Pbthldlnop
mm.ng. mm*Eg*
10 - 19. 10 3*8
20, 3 2*7
16
subjects anaesthetl2ied by vasodilator techniques. 
The value obtained for was 6.97 (P<0.01), 
thus establishing a significant difference in 
response to intravenous Ergometrine.
E. FKTHIDIlnE H h h l M B .
The effect of intravenous pethidine on 
the circulatory response to Ergometrine is 
negligible, as will be seen from reference to 
Table XIXI across. In the two groups studied, 
the average drop in pressure after receiving 
pethidine was 3.8 mm.Iig., in the one and 
2.7 mrn.Bg., in the other. This result indicates 
that any papaverine « like action attributable 
to pethidine is vary weak and certainly of no 
value in the protection of susceptible subjects 
from the vasoconstrictor activity of Ergometrine.
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DISCUSSION.
A. imoEEiiCAL oomiDEmiiom.
The alkaloids of ergot may foe divided Into 
two groups on a basis of pharmaoo1og1ca1 activity. 
The first group contains the alkaloids of higher 
molecular weight. These are noted for the 
complex effects on the cardiovascular system that 
result from their ability to depress central 
vasomotor reflexes and to block the pressor effects 
of sympathetic nerve stimulation. The second 
group, of which Ergometrine is a member, shows 
little adrenergic blocking activity.
One form of activity common to both groups 
is direct stimulation of the smooth musculature 
of blood vessels with consequent vasoconatrlctlon. 
This effect has been demonstrated experimentally 
by perfusion of Isolated blood vessels and by 
administration of the compounds to pithed and 
intact experimental animals.
This direct and non-adrenerglc form of 
vascular activity la pronounced in the ergot
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alkaloids of higher molecular weight, such as 
ergometrine, ergosino and ergocristine- 
Moreover, these same compounds produce capillary 
endothelial damage, vascular thrombosis, and tissue 
gangrene.
Of all the naturally occurring alxaloids of 
ergOt, Ergomotrine probably possesses the least 
vasocons trietor activity- Gangrene has never
been attributed to the administration of 
Ergometrine, and vasoconstrictor activity is 
believed to parallel the tendency of these 
substances to precipitate gangrene (Goodman & 
Gilman, 1960).
Relatively little study has been devoted to 
the vasopressor effects of Ergometrine ; Indeed 
some standard works attribute no such activity 
to it within the therapeutic range (Wood - Smith 
and Stewart, 1968 ; Douthwaite, 1949 ; Micks,
I960). Nevertheless, there does exist experimental 
evidence in support of the pressor action of this 
aljKalold, and clinical experience has resulted 
in the occasional report in medical literature
8o
of hypertension following exhibition of the drug 
in obstetrics, (Forman ^ dullIvan, 1952 ; 
Dieckraann et al., 1950 5 Schade, 1951 ; Hamilton 
et al., 1952 i McGinty, 1956).
PRESSOH HBbPONdE In H<E-EGLaMPSIA .
The results obtained In this investigation 
from the 256 patients anaesthetized by the 
thiopentone, sucolnylcholtne, nitrous oxide, 
oxygen sequence, demonstrates an interesting 
relationship between the vasopressor action 
of Ergomotrine maleato and differing states of 
camiovascular integrity - normotension, 
hypertensive toxaemia of pregnancy, and chronic 
hypertension complicating pregnancy.
The most compelling feature portrayed by 
Tables I - IV is the fact that a high percentage 
of women with pro-eclamptic toxaemia of pregnancy 
respond to the intravenous Injection of 0.5 mg. 
Ergometrine by producing a significant elevation 
in systemic blood pressure. That there is in 
pre-eclampoia an abnormal sensitivity of the
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vasoconstrlotor mechanism was first shown by 
Shockaert ana Lambillon (1937) who discovered 
that normal gravid women and women suffering 
from pre-eclamptlo toxaemia react differently 
to injections of *Tonephin*, the toxaernic 
patients being much more responsive. 
Simultaneously, Diaokmann and Michel (1937) 
obtained similar results from the administration 
of pltuitrin to nulliparous woman, healthy 
pregnant women, and patients with hypertensive 
toxaemia. Confirmation of the results of 
these two studios followed from do Valera and 
Heliar (1938) and Mukherjee (1941), also using 
pltuitrin, and from Dieokmann (1941), employing 
on this occasion the cold pressor test.
The results of the investigations of all 
these authors agree that in patients suffering 
from acute toxaemia of pregnancy, as compared 
with the nulliparouB female, and the healthy 
gravida at term, a marked pressor response will 
be elicited by a standard amount of pressor 
agent. Browne (1946) had the opportunity of
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noting the difference In pressor response to 
*Ton©phin’ 0.66 cc. intravenously in two patients 
who subsequently developed pre-eelamptic toxaemia, 
and found that, after developing toxaemia, these 
women, previously normal, had an abnormal increase 
in sensitivity of the vascular bed. In one 
patient the pressor agent caused a rise in systolic 
blood pressure from 100 mm to 170 mm.Bg., and in 
the other from 132 mm to 190 mm.Bg.
It appears from Table I that the well- 
integrated vasomotor mechanism of the healthy, 
normotenslv© parturient wom^ Lii is relatively 
unresporiBive to the pressor activity of 
Ergom©trine. On the other hand, Tables II and 
IIX bear ample evidence that the vascular bed 
of the toxaernic patient reacts to Ergometrine, 
administered Intravenously, by constriction.
This finding is in keeping with the observations 
of the authors quotoo above in respect of other 
vasopressor agents.
Since Ergometrine in the dosage employed 
is alone incapable of evoking a pressor response
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In the normotenaive individual, it 1b possible 
that abnormal sensitivity of the vascular bed 
is not the sole reason for the increase in 
systemic blood pressure in toxaernic women. It 
may be that Ergometrine and a pressor substance 
responsible for the already existing hypertension 
of pre-eclampsia react synergistically. vVeight 
is given to this suggestion by the fact that 
marked hypertension can be produced in previously 
normotensive individuals by Ergometrine in 
combination with certain other pressor agents.
Casady, Moore and Bridenbaugh (1960) 
examined the obstetric records of 757 women who had 
had vaginal deliveries under caudal extradural 
analgesia. In order to counteract any drop in 
blood pressure, 6 - 1 2  mg., methoxamln© had been 
2^;lven as a routine measure on completion of the 
block. At the time of placental delivery,
Ergometrine 0.23 mg. or methyl ergometrine 0.2 mg. 
was given intravenously. Severe hypertension 
from the combined effect of the peripheral 
vaBOConstrietor and the oxytocic agent resulted
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in 34 patients, one of whom developed a 
subarachnoid haemorrhage when an intraoranial 
aneurysm ruptured at a blood pressure of 
180/120 min.%.
Oxytocin contains the oxytocic principle 
of the posterior pituitary gland, and whilst 
relatively free from vasopressin, it is not 
completely so (Dundee, 1958)* In consideration 
of the fact that the existence of a state of 
abnormal sensitivity of the vasoconstrictor 
mechanism, whether due to a circulating pressor 
agent in pre-eclampsia, or to an artificially 
introduced vasopressor drug such as methoxamine, 
enhances the likelihood of a hypertensive 
response to Ergometrine, it is not surprising 
that there should appear in the literature 
accounts of dramatic elevations of blood pressure 
in women who have received a combination of 
Ergometrine and oxytocin. Hamilton et al., (1952) 
cite two instances in which the simultaneous 
Injection of Ergometrine 0.2 m^., into a vein 
and of * Pi toein* 1 cc. into the myometrium
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precipitated such a hypertension in previously 
normotensive women. The blood pressure rose
from 118/72 rrim. to 178/100 mm.hg., in one and 
from 112/66 mm. to 180/110 mm.Bg., in the other.
Of three women in the current inquiry who 
received 0.5 ing. Ergometrine intravenously while, 
or just after, having an infusion of synthetic 
oxytocin (*Syntocinon*J, none displayed an 
appreciable rise in pressure. ithout doubt, 
this contrast in side-effect between the naturally- 
occurring and synthetically produced compounds, 
stems from the absence of any vasopressor 
element in the latter*
when the sympathetic system is blocked 
during anaesthesia, most of the normal compensatory 
vascular mechanisms are abolished and a great 
augmentation of response to vasoactive drugs 
occurs (bromag©, 1954). It is possible, 
therefore, to postulate an alternative explanation 
for the severe hypertension that may follow the 
combined use of Ergometrine and other vasopressor 
agents. Substances which block autonomic
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ganglionic transmission increase the response 
of the arteriolar system to a variety of 
circulating pressor agents. This effect has 
been demonstrated on cats, dOgS, rats and human 
beings by Page and Taylor (1950).
The mechanism of augmentation was shown by 
these workers to oe due chiefly to loss of 
inhibitory or compensatory nervous mechanisms, 
which, in the intact Individual, tend to oppose 
changes in blood pressure. However, any effect 
on the autonomic ganglia exerted by krgometrine 
is not to be compared in potency with the blocking 
effect of the alkaloids of ergOt that possess a 
polypeptide slde-chain.
SYSTEMIC EFFECT OF ERGOMETRINE IN CIIRQNIG 
HYPERTENSIVES.
Table IV affords evidence that in the 
severely hypertensive group, i.e. women with a 
resting diastolic blood pressure greater than 
110 mm.Bg., the incidence of the vasoconstrictor 
response Is decreased. This apparent discrepancy
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results from the fact that many of the obstetric 
patients encouïiterad with a systemic pressure of 
this order, suffer from a chronic form of 
hypertensive cardiovaacular disease, and not from 
hypertensive toxaemia of pregnancy. The 
exclusion of the chronic hypertensives from 
Table III produces a vastly different incidence 
of pressor response to the ergOt alkaloid,
(Table V).
Eleven of the patients anaesthetized by the 
barbiturate, muscle relaxant, nitrous oxide gas 
and oxygen technique bore an ante-natal diagnosis 
of chronic hypertension. All but one failed to 
show an elevation in systemic blood pressure 
after Intravenous injection of the oxytocic 
agent* The exception, whose basal pressure 
was 160/100 mm.Eg., produced an elevation of 
12/6 mm.Bg., throe minutes after injection, 
modest Indeed in comparison with the elevations 
elicited in other women of comparable resting 
blood pressure. Obviously, then, women who 
suffer from severe chronic hypertension and
88
who are free from the clinical features of 
toxaemia, do not exhibit a vasoconstrictor 
response to Ergometrine administered 
intravenously.
One patient in the series suffered from 
hypertension of chronic nephritis and presented 
with a resting blood pressure of 145/95 mm.hg. 
Her pre-ergometrine level of pressure was 
maintained following injection of the alkaloid.
The above findings in respect of patients 
with chronic hypertension can be associated with 
the fact that the systemic blood pressures of 
pre-eclamptic patients and of women with 
hypertensive cardiovascular disease differ in 
spontaneous behaviour. Wërko and Brody (1953) 
found that the blood pressure in hypertensive 
cardiovascular disease did not share the 
spontaneous diurnal variability of the blood 
pressure in px‘e-eclamptic toxaemia.
Bammarstrflm, six years previously, had 
shown that the absence of variability of the 
blood pressure in hypertensive cardiovascular
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disease was also characteristic of chronic 
nephritis.
It is possible that Table XI contains some 
cases of early essential hypertension, and also 
possible that any such patients might produce 
a response to intravenous Ergometrine of the 
type seen in pre-eclamptic women* Before 
structural changes become established in the 
artex^iolar wall of the early chronic hypertensive 
individual, the mechanism responsible for the 
increase in peripheral resistance is an active 
contraction of the vessel, due to sympathetic 
hyperactivity, or to the influence of some 
circulating vasopressor agent, or perhaps to 
a combination of the two. It is known that in this 
early phase, patients show considerable fluctuations 
of systolic blood pressure with exaggerated 
responses to application of sensory stimuli or to 
emotional stress. It la not, therefore, beyond 
the realms of possibility that the lack of 
response to Ergometrine in chronic hypertension 
applies only to patients in whose arterioles
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histôlogioal changes have already occurred 
and whose rang© of pressure change has, for this 
latter reason, become limited.
association of i m  PREbdOR EFFECT WITH PLUR/iL 
PREGNANCY.
Eight normotensive women who were delivered 
under nitrous oxide ; muscle relaxant anaesthesia 
showed an elevation of blood pressure of at 
least 20 mrn.irig* The remarkable fact is that 
seven were cases of normotensive plural pregnancy. 
Their response was of the type that the results 
of this investigation have come to associate 
with a state of increased circulatory tone.
Bad these woman been suffering from 
hypertensive toxaemia, an explanation for this 
occurrence would have been readily available, 
since there is an increased incidence of this 
disorder In oases of plural pregnancy, a 
subject ably reviewed by Bulfin and Lawler
(1957). Working at the Little Company of 
Mary hospital, Chicago, these clinicians
91
noticed that the systemic effects of the 
alkaloids of ergot were more pronounced in 
the patient whose uterus was contracting after 
distension from a twin pregnancy.
Sophian (1953) has long been an 
enthusiastic protagonist of the Trusta mechanism 
(Trueta et al., 1947) and the initiation of a 
utero-renal reflex by conditions associated 
with Increased uterine tension. On this basis 
he explains the high incidence of pre-eclamptic 
toxaemia in patients with plural pregnancy and 
hydatidlform mole. According to Sophian, the 
utero-renal reflex is associated with the 
release of humoral substances by the Ischaemic 
kidney, and these pressor substances, in turn, 
increase the vascular tone of the peripheral 
blood vessels.
On this attractive theoretical argument, 
it is easy to postulate that the circulation 
of the seven women who gave birth to twins, and 
who developed a hypertensive pressor response 
to Ergometrine, had lost Its normal integrity
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and assumed a state of sensitization or 
angiospasm# However, it im difficult to 
envisage the ooexistance of such a circulatory 
state and normotension.
HYPOTENSION GQXNCIDINQ WITH ADMINISTRATION OF 
EHOOMETKINB*
The intravenous injection of Ergometrine 
in three patients with severe pro-eclampsia 
coincided with the development of a sudden 
drop in pressure of 80, 30 and 50 mm.Bg., 
respectively. To one woman only, methoxamine 
was administered with a satisfactory response. 
Despite the reduction in systolic pressure by 
80 and 30 mm., respectively in the other two, 
neither received a vasopressor agent since the 
clinical condition of the patient did not give 
rise to anxiety and the dangers associated 
administration of a vasoconstrictor agent seemed 
to outweigh the advantages.
The reason for the development of the 
relative hypotension in these three toxaernic
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women is open to argument. Before pondering 
over this problem, it is to be noted that not 
even minor decrees of hypotension occurred in 
f^ ny other patient in the absence of operative 
haemorrhage ; apart from these three toxaernic 
women, the patients either retained their 
pre-ergometrine level or showed an elevation 
of arterial blood pressure.
hypotension due to haemorrhage is ruled 
out since the loss in none was more than 10 f1. 
oz •
The depolarizing muscle relaxant employed 
throughout the series is knovm to affect cardiac 
rhythm and rate (Bullough, 1969). Sinus 
bradycardia, depression of the excitation and 
conauction of cardiac impulses, and even complete 
arrest may be produced by succlnylcholine 
(Lupprlan ôc Churchill - Davidson, 1960). The 
size of the incremental dose of succlnylcholine 
and not the frequency of administration seems to 
be the important factor. Six out of seven 
patients who developed ventricular standstill in
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the report by Lupprian ^ ^hurchill « Davidson, 
did so after a repeated dose of at least 
50 mg*, twice the magnitude of the increments 
employed during this inquiry* It may be that 
Jirgometrine and sucoinyloholine, given at or 
about the same time, form a dangerous combination.
#as hypotension produced in the three pre­
eclamptic women as a result of adrenergic 
blockade? It is said that compounds like 
Ergometrine, that do not possess a polypeptide 
side-chain, lack the ability of the other 
naturally occurring alkaloids of ergot to block 
and reverse the pressor effects of adrenaline 
and sympathetic nerve stimulation. (Goodman Sc 
Gilman, 1960). An argument against the 
likelihood of sympatholysis from this drug la 
the fact that all three patients had received 
thiopentone ten minutes before administration of 
Ergometrine, and the thiobarblturates are known 
to reduce the adrenergic blocking potency of the 
ergOt alkaloids (Goodman à Gilman, 1960).
One factor that cannot be overlooked is the
ability of ergot alkaloids to depress the 
myooardium directly, so reducing cardiac output. 
ErgOt derivatives have long been known to afford 
protection against cardiac arrhythmias, a 
property supposedly due to myocardial depression.
Cases of circulatory collapse have occurred 
following the injection of pituitary extract 
during anaesthesia with certain agents, including 
thiopentone, and have been attributed to a 
combination of myocardial depression and 
myocardial ischaemia. That the alkaloids of 
ergot depress the myooardium has just been noted. 
It is not commonly appreciated, however, that the 
naturally occurring alkaloids are potent 
constrictors of the coronary arteries (Katz and 
Linder, 1939). Even at normal oxygen tensions, 
Ergornetrine has produced anginal pain in 
susceptible subjects.
One cannot ignore the fact that all three 
patients who became relatively hypotensive 
presented with the clinical features of 
hypertensive toxaemia. in all three the raised
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preoperativ© blood pressure was accompanied 
by albuminuria and widely distributed tissue 
oedema.
Lastly, the decline in systomlc pressure 
could have been evidence of reflex activity, 
emptying of the uterus providing the afferent 
stimulus. Bapid evacuation or decompression
of a space-occupying intra-abdominal tumour 
commonly evokes such a reaction# This might 
apply equally to evacuation of the womb at term 
as to rapid decompression of the urinary bladder, 
rupture of a large ovarian cyst, or paracentesis 
of an ascitic abdomen#
THE INFLUENCE OF Ba LOTBa NE ON TEE PRESSOR EFFECT
OF ERGOMBTRINE.
halothane anaesthesia produces a fall In 
arterial pressure that is considered to be due 
to a combination of vasodilatation and diminution 
of cardiac output.
The inhalation of halothane vapour rapidly 
produces vasodilatation and reduction in 
vascular resistance that persist throughout the
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period of aaaesthoBia (Johnstone, 1956).
This vasodilatation was shown by black and 
McArdle (1962) to be due to the release of 
vasoconstrictor tone, although the localized 
action of halothane on the vessel wall does 
play a part (Burn & Epstein, 1959). halothane 
also modifies the action of noradrenaline on 
peripheral blood vessels.
Catecholamines influence the blood pressure 
not only by their action on peripheral blood 
vesselsj but also by their effect on cardiac 
output, since they are liberated at the cardiac 
sympathetic nerve endings (Ansola & Kushmer, 
1956). During halothane anaesthesia there is 
no compensatory increase in the secretion of 
adrenaline and noradrenaline (Black & McArdle, 
1962) so that the heart is depressed more readily 
by the anaesthetic and cardiac output falls.
The fact that halothan© will inhibit 
effectively the vasoconstrictor activity of 
intravenous Ergometrlne has been borne out 
adequately by the results of the current
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investigation* what has now to be determined 
is whether or not, as a result of these findings, 
the nitrous oxide, oxygen, relaxant technique 
of anaesthesia should now be displaced by one 
of the more vasodepressant forms of anaesthesia 
for patients suffering from hypertensive toxaemia 
of pregnancy.
The place of halothano in obstetrical 
anaesthesia has yet to be determined, despite the 
fact that this agent has been subjected to more 
experimental and clinical trial than any anaesthetic 
agent hitherto. This results largely from reports 
of extreme uterine relaxation and post-partum 
haemorrhage associated with its administration.
That halothane is a potent relaxant of the 
pregnant uterus has been amply attested to by 
the clinical reports of MacKay (1957), Russell
(1958), ana Albert et al. (1959) and by th© 
tocographic studies of Embrey et al (1969).
Should this relaxation be profound, no 
improvement in uterine tone can be expected from 
injections of oxytocic posterior pituitary extract
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(Albert et al,, 1959) or from Ergometrine 
(Russell, 1958). Comfort lies, however, in 
the fact that on withdrawal of the anaesthetic 
agent, the uterine response to halothane 
disappears as rapidly as it occurred. It is 
in the face of these facta that the place of 
haiotharxe has to be considered in this special 
situation where the circulatory effects of 
Ergornetrine might well be a danger to the patient.
In none of the eight pro«eclamptic women 
anaesthetized by halothane in the present study 
was the level of anaesthesia profound, nor was 
there any obvious interference with uterine 
contraction and retraction, yet the depth was 
sufficiently adequate to afford protection from 
the pressor activity of the oxytocic agent.
One woulü appear to be justified, therefore, 
in concluding that adequate protection is 
offered by a level of halothane anaesthesia 
insufficient to interfere with uterine retraction. 
Vasodilatation and reduction in vascular 
resistance do occur during light anaesthesia
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with this fluorinated hydrocarbon (Johnstone, 
1956) so that at least on© definite indication 
for the display of halothane in obstetrical 
anaesthesia has been established.
modification of i m  ERGQMETRXNE effect by
DX-EimL ETHER.
The combination of nitrous oxide, oxygen, 
and di-ethyl ether has long been the method of 
anaesthesia most commonly used for obstetrical 
procedures, firstly because of its safety, and 
secondly on account of Its simplicity in the 
hands of the Inexperienced or occasional 
anaesthetist. In recent years, the use of this 
anaesthetic method has been on the decline, for 
reasons that include.its unpleasantness to the 
patient, its flammabillty, and its depressant 
effect on the foetus.
The results of the current investigation 
indicate that it is now time for an appraisal 
of the place of ether in modern obstetrical 
anaesthesia. In any obstetric situation
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involving delivery under general anaesthesia, 
the technique employed by the anaesthetist must 
have regard not only for the nature of the 
maneouvre contemplated, but also for the presence 
of any placental pathology, for the depressant 
effect of anaesthetic and analgesic drugs on 
the foetus, and not least for any particular 
pathological entity in the motner# In 
recognition of the last of these factors, the 
significant depression by ether of the 
Ergometrine effect on the peripheral vascular 
bed of pre-6clamptic women might claim for 
this drug a better defined place in obstetrical 
anaesthesia•
The mechanism whereby dl-ethyl ether 
inhibits the Ergornetrine effect on arteriolar 
tone is not easily explained. Textbooks of 
anaesthesia and pharmacology (Lee, 1953 ;
Adrian!, 1952 ; Minnitt & Gillies, 1949) 
traditionally ascribe to this drug a vasodilator 
action, due, firstly, to depression of the smooth 
muscular coats of the arteriolar wall, and secondly,
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to partial paralysis of the vasomotor centres.
In actual fact, so many actions have bean 
attributed to ether, as a result of some well- 
conducted and other less reliable animal 
experiments, that It is possible to invoke 
such explanations for circulatory changes as 
the occasion demands or as the investigator 
require© to suit his particular argument. For 
example, apart from the direct actions of other 
on the myocardium (Prime ^ Gray, 1952 ; Price & 
Helrich, 1055), on the peripheral blood vessels 
(Bhatla & Burn, 1933), and on the vasomotor centres 
(Embley, 1902), this anaesthetic drug affects the 
heart rate and systemic blood pressure reflexly 
by increasing the sensitivity of the baroreceptors* 
It also causes general sympathetic stimulation 
through a central action on the nervous system 
(Elliott, 1912 ; Beattie, Brow & Long, 1930 ;
Bhatla & Burn, 1933 ; #atts, 1956).
it is undoubtedly true that di-ethyl ether 
causes vasodilation, but the evidence in favour 
of the usually emphasized direct vasodepression
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and medullary vasomotor paralysis as factors 
of impor tance in clinical dilatation, is 
scanty (Robertson, 1957). The speed with which 
arteriolar dilatation occurs following 
administration of ether anaesthesia may well be 
related to increased sensitivity of the 
baroreceptors, which has been shown to occur in 
light anaesthesia. Vasodilatation is most 
marked in the vessels of the limbs and skin and 
is comparatively long-lasting (Robertson, 1967).
CYGLQPHOPa NE ITS INFLUENCE ON THE 
ERGOmTRIhE EFFEGT.
The foetal blood level of cyclopropane 
rapidly attains and follows the maternal blood 
level of that drug, and since it Is a profound 
depressant of the respiratory centres, this 
hydrocarbon has been unable to find popularity 
with obstetric anaesthetists. a second reason 
for its lack of popularity in this field 
emanates from reports of collapse and sudden 
death due to a combination of cyclopropane
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and Injections of posterior pituitary extract.
(Lesser à Eason, 1954).
In the two groups of patients to whom 
cyclopropane was administered, the level of 
anaesthesia attained was light and not sufficient 
to interfere materially with the functions of 
the foetal respiratory centres. The maintenance 
of a light plane of anaesthesia in both series 
was deliberate, not merely because there was 
no indication for profound depth of narcosis, 
but primarily to explore the effect of the method 
on the vascular bed of toxaomic women who were 
receiving Ergometrine. Ilitohen et al. (1953)
demonstrated conclusively that the vasodilatation 
caused by this saturated hydrocarbon is maximal under 
light anaesthesia.
It has been indicated already that the scope 
of cyclopropane in obstetrics is largely limited 
to the Inhalational induction of anaesthesia for 
extraction of the head in breech delivery. The 
findings In respect of its inhibition of the 
Ergometrine effect in pre-eclamptic women do not
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compel the author to plead for an extension 
of the use of this drug In the treatment of 
such patients ; halothane and di-ethyl ether 
are to be preferred In other forms of operative 
delivery* Nevertheless, It is reassuring to 
know that in the one form of obstetric delivery 
in which cyclopropane is mainly Indicated, pre­
eclamptic patients are not exposed to the 
hazards of severe rises in blood pressure 
resulting from the oxytocic injection*
B* FHACTXQAXi i m p l i c a t i o n s*
Ca rdiac DISEASE GOMPLIOATim PREGNANCY*
Several mechanisms, physiological, 
pathological and pharmacological, may cause 
sudden hypertension In the puerperiurn* Of the 
physiological causae, one commonly cited is the 
contraction and retraction of the uterine 
musculature, exaggerated in intensity by the 
action of oxytocic drugs, which z^esuits In the 
transfer of a laz’^ e volume of blood from the 
uterine reservoir to the aXz^eady overloaded
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Intravascular compartment. Doubt its oast on 
the impoz'-'tance of such a mechanism in the 
production of hypertension by some aspects of 
the current study, notably by the results of 
delayed injection of Ergorne trine, detailed in 
Table VXXl. Any tendency to increase the 
circulating blood volume must be offset partly 
by blood loss during parturition, particularly 
in operative deliveries.
Cardiac failure is a well z^ecognised 
complication of heart disease in pregnancy and 
the mortality rate rises progresslvel^f as term 
is approached to reach a peak at parturition 
and the immediate post-parturn period. (Jensen, 
1938). Some deaths resultlxzg from cardiac 
failure, at or about the time of delivery, have 
been associated with the administration of 
Er^x,ometrine (Edwards et al., 1966) but the 
validity of the reasons given for implicating 
this drug are open to question. Two authors 
(Eoffrnan & Jeffez»s, 1943) have likened the effect 
on the maternal circulation of poat-pa.rturn
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uterine contraction to that of the rapid 
intravenoua transfusion of blood, and, on 
acceptance of this principle, others (Edwards 
©t al., 1956 ; Friedberg, 1956) have campaigned 
against the use of the ergot alkaloid in patients 
with cardiac disease. It is here contended that 
systemic hypertension is unlikely to occur in 
cardiac disease, in the absence of hypertensive 
toxaemia or multiple pregnancy, and that when it 
does present, the rise in blood pressure results 
largely from an increase in peripheral resistance 
rather than from a raised circulating blood 
volume #
In one of the two fatalities reported by 
Edwards and his associates, acute toxaemia of 
pregnancy was superadded to the cardiac 
disability ; in the other, relevant details are 
not given.
It must be streseed, however, that the 
remarks made above refer to the systemic arterial 
circulation and not to the pulmonary circulation. 
During the latter months of pregnancy, the venous
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return from the lower limbs le Impeded by 
pressure of the gravid uterus on the inferior 
vena oava, particularly in the recumbent 
position. After parturition, there takes 
place an increase in venous return to the 
heart, assisted by descent of the diaphragm 
and the consequent decrease in mediastinal 
pressure (Montgomery et al., 1958). Thus 
there la a reasonable argument in support of 
pulmonary hypertension following delivery and 
a probable mechanism for the production of 
acute pulmonary oedema in women with cardiac 
disease, but the factors primarily concerned 
in their precipitation are not referable to 
the oxytocic activity of Ergometrine*
p o a T - F A H T U M  E G  L a m p s  Ii\*
Of pathological entities causing hyper­
tension in the puerperium, the most Important 
clinically is pre-eclampsia. From time to 
time, there appear in the literature reports 
of post-parturn eclamptic convulsions, sometimes
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In patients who had no evidence of ante-partum 
toxaemia (Slander et al., 1946 ; Schade, 1951 ; 
Hofmelster & Brown, 1953 ; Hamilton, 1953 ; 
McFadyen, I960)*
Post-parturn eclampsia, of course, was a 
recognised clinical hazard in days preceding 
the widespread Intravenous administration of 
Ergorne tz’‘ine ma lea te, but the fact that this 
drug is capable of evoking an elevation in blood 
pressure of up to 46 mm.Hg. in pre-eclamptic 
women cannot be ignored as a possible contributing 
factor in the precipitation of fits in such 
patients.
Spasm of small blood vessels is an important 
feature of th© entire disease process of toxaemia 
of pregnancy and, whether it is the fundamental 
pathological basis or merely a secondary 
rnanifestation of the disease, the fact remains 
that in this condition the vascular bed is in 
a state of sensitization and readiness for the 
production of an additive and intense 
vasoconstrictor response to Ergornetrine.
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Ergornetrine maleate appears to act in a 
synergistic manner on the peripheral blood 
vessels when given with a vasopressor substance, 
whether that substance be a pharmacologleal 
agent such as methoxamine, or a physiological 
one Such as pituitrln or the pressor substance 
of pre-eclampsia. Just as the cumulative 
effect of the ergot alkaloid and vasopressor 
drug may be out proportion to the expected 
reaction from individual Injection of either, 
so the vasoconstrictor response to Ergometrine 
in the pre-eclamptic patient might be 
sufficiently intense to precipitate an eclamptic 
seizure.
There would seem to be a fair amount of 
evidence to support a plea for the use of 
smaller doses of Ergometrine in patients with 
toxaemia of pregnancy. The post-parturn uterus 
Is extremely sensitive to action of this 
alkaloid, positive effects having been produced 
with less than 0.05 mm. intravenously (Smith, 
1938). 0.3 mg., has been described as the
I l l
optimal intravenous dose (Adair et al., 1935) 
and is that commonly employed in centres in 
the United States of America. In Moir’a 
(1944) opinion, an amount of 0«25 mg*, should 
never be exceeded by Intravenous injection.
Observation of patients under the narcotic 
Influence of tribromethanol, suggests that this 
alcohol protects severely tozaemlo patients from 
the vasopressor response to Ergornetrine. One 
such patient occmTOd in the current investigation 
and the results obtained in her case have been 
substantiated by my recent observation of the 
effect of the oxytocic drug on three women under 
tribromethanol narcools, who did not require 
general anaeetheola for delivery. The apparent 
protection offered by this basal narcotic results 
from its two-fold action on the oiz'culatory 
system, firstly depression of the vasoftiotor 
centres in the medulla, and secondly relaxation 
of the walls of the smaller blood vessels 
(Lea, 1953).
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IN TKACHaNIa l BaEMOHRHaQE.
Casady et ai (1960) have given fresh 
emphasis to the risk of subarachnoid and intra- 
Gez'Cbral haemorrhage in hypertensive v/omen and 
in their recent paper cited nine oases of post­
partum hypertension with cerebral haemorrhage 
following injection of a vasoprosaoz*' agent, an 
oxytocic drug, or a combination of the two. 
Included in their review of pos t-pai**tum 
cerebral catastrophies was the case repoz’t of 
one of their own patients who had a subarachnoid 
haemorrhage from a ruptured intracranial 
aneurysm within two hours of delivery. Delivery 
in this case was effected under caudal epidural 
analgesia, and to counteract any tendency towards 
hypotension as a result of the block, methoxamine 
10 mg. was administered. At the time of 
placental delivery, 0.23 mg. Ergornetrine maleato 
was given, whereupon the systemic blood pressure 
rose from 120/76 mm. to 180/120 mm.Eg., and at 
that pressure rupture of the aneurysm occurred.
The additional influences on the blood
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pressure of psychomotor activity and voluntary 
movement might well render the Brgom©trine 
effect a greater hazard to conscious than to 
unoonscious patients. Certainly, these two 
and other factors cause wide variations in the 
pattern of blood pi^essure when hyper tensive 
patients recover from general anaesthesia.
Personal observation has been made of the 
Influence of certain phenothlazlne derivatives 
and on environmental and bed temperatures on 
these women {Baillle, 1962). in recent years 
it has been the practice to return patients 
from the operating suite to a cool bad in order 
to avoid peripheral vasodilation and hypotension. 
Here is an Indication foz^  reversal of that 
general rule and the application of moderate 
vvarmth*
ACCIDENTAL HaEMDEEBaGK.
Obstetricians not uncommonly experience 
anxiety over the suppression of urinary secretion 
in patients suffering from accidental haemorrhage.
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Although the cause of the renal tubular damage 
associated with concealed accidental haemorrhage 
is still unknown, it is believed that damage to 
uterine muscle fibres releases myoglobin into 
the circulation. This, possibly in association 
with shock, causes constriction of the renal 
vessels, in particular the arterioles supplying 
the tubules* Should this arteriolar spasm 
persist unduly long, therefore, tubular damage 
or even necrosis will ensue*
One is led to wonder how great or significant 
effect the aamlnlstz'ation of trine exerts
on such renal angiospasm. It is always difficult 
to tz’anslate the inferences of animai experiments 
in tei'^ins of clinical effects on huxnan beings, but 
the fact that Ifrgometrlna does constrict the renal 
arteriolar vessels in the experimental animal 
(Hamet, 1935), cannot be ignored. In the 
absence of more precise knowledge of th© 
influenco of this oxytocin agent on the blood 
vessels of the human kidney during pregnancy, it 
is probably wise to concur with Byrom and Pratt (1962)
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who stale that In this connection, all potential 
vasoconstrictors must be suspect*
8ELEGTI0N OF ANABSTHESIA*
Since most foz^ ms of conduction anaesthesia 
are regarded as unsuitaola for obstetrical 
emergency procedures (Bingson & Bellman, 1956 ;
Apgar et al., 1957 ; Orawford, 1959), general 
anaesthesia is required for the greater number 
of operative deliveries.
The selection of a particular general 
anaesthetic technique, however, is not a simple 
one, since a great number of factors must 
influence the ultimate choice. As in the 
provision of anaesthesia for general surgical 
procedures, the physical condition of the patient, 
the specific pathological process demanding 
surgical Intervention, the type and site of 
operation envisaged, and any particulaz*» vagaries 
of the surgeon have to be catered for# Application 
of these factors alone to obstetrical anaesthesia, 
whilst providing pleasant and safe anaesthesia
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for the mother and ideal operating conditions 
foz* the obstetrician, might nevertheless 
inflict untold harm on the foetus. Thus, in 
anaesthesia for any obstetrical maneouvre that 
Is likely to culminate in delivery of the 
Infant, further consideration must take into 
account the ease of placental transmission of 
the naz“-cotlo drugs used and their action on 
the foetal medullary respiratory mechanism, 
especially In the presence of foetal distress 
or prematurity.
Evaluation of diffez^ent anaesthetic 
sequences must be carried out in the light of 
these latter, foetal factors# In consequence, 
some acceptable means of assessing the viability 
of babies delivered under the various methods of 
narcosis is necessary. This is provided quite 
conveniently by calculation of the Apgar score 
(Apgar, 1953), or even more simply by estimation 
of the delivery,- breathing and delivery - 
crying times (Hodges et al., 1959).
By employing the lattei'^  methoci, Hodges,
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Bennett and Tunstall (1959) compared the effects 
on the foetus of four anaesthetic techniques; 
thiopentone, succinylcholine, nitrous oxide and 
oxygen, cyclopropane and oxygen, nitroue oxide, 
oxygen and ether, and nitrous oxide, oxygen and 
trlehlorethylene.
The absence of foetal depression in babies 
whose mothers were anaesthetized by the first 
of these sequences, was so outstanding that, 
wherever a specialist anaesthetic service is 
available, the nitrous oxide muscle relaxant 
method has won for Itself universal adoption.
The theme of this thesis, however, suggests 
that this form of anaesthesia is not a suitable 
one for women presenting with the clinical 
features of acute toxaemia of pregnancy, in view 
of the significant incidence of hypertension 
that follows intravenous administration of 
Ergornetrine in such cases.
fhllst there may be a case for the use of 
a smaller dome of the oxytocic drug in the 
presence of hypertensive toxaemia, there is
118
nev©rthel6fôfô contained In the results of the 
present study, a challenge to outer for yet 
another aapect of obstetrical anaesthesia.
Halothane, dl-ethyl ether and cyclopropane 
have all been shown to modify the pressor 
response to Broometrine. Their acceptability, 
therefore, depends on the ratio of their 
capacity to inhibit the Ergornetrine effect to 
their depressant effect on the foetus*
The recent intz’oduction of the fluorlnated 
hydrocarbon, halothane, into anaesthetic practice, 
resulted inevitably in the exploration of its 
possible virtues In obstetrics* Montgomery 
(1961), in a comparison of the Apgar scores 
(Apgar, 1953) of infants born by Caesarean 
section using the Hodges technique and of those 
delivered by the same operation employing a 
ha10thane anaesthesia, demonstrated that halothane 
given la a conoexztration of I - 2% (l.e* vaporizer 
concentratlon) was much more depressant to the 
newborn than nitrous oxide and oxygen in 
combination wi th succinylcholine * The scoz’es
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obtained by Montgomery in respect of halothane 
closely paralleled those of Ap^er (19513) usin^ 
cyclopropane, and from the foetal point of 
vi@r/, therefore, there seems to be little to 
choose between the two.
Over and above its depressant effect on 
the foetal medulla, halothane is a potent relaxant 
of the (^ravid uterus (MaolCay, 195? ; Russell,
1950 I Albert et al,, 1959 ; Embrey et al., 1959), 
and to the hazards attendant on the latter action, 
reference has been made already* It has been 
stated, therefore, (Crawford, 195^) that the 
exhibition of halothane should be limited to 
cases requiriHf^ uterine relaxation, e.g# 
external cephalic version when uterine 
hypertonicity ia impeding the manipulation, acute 
inversion of the uterus, and operative 
difficulties associated with constriction ring 
formation.
In the author's opinion, however, the scope 
of this useful fluorinatad hydrocarbon must be 
broadened to include anaesthesia for pre-eclamptic
120
women. Profound depth of narcoals, sufficient 
to Interfere with retraction and contraction of 
the uterus is unnecessary to inhibit the 
Er^ometrine effect since even ll^ht halothane 
anaesthesia produces marked peripheral 
vasodilation (Johnstone, 1956). Even before 
the level of blood pressure starts to decline, 
vasodilatation is in evidence, the maintenance 
of pressure bein^  ^attributable to an increase 
in cardiac output at this li^ht plane (Blaqk 
and McArdle, 196^).
The enthusiastic reports concerning the 
use of halothane in obstetrical anaesthesia 
(Brown and wVoods, 1958 ; Sheridan and Robson, 
1959), tend to suè^^eat that, as with so many 
other types of therapy, the man is more important 
than the me thod .
kVith regard to cyclopropane, a degree of 
foetal medullary depression comparable with that 
of halothan© has been noted. Largely for this 
reason, trimethylene has oeen almost abandoned 
in this country as an anaesthetic agent for
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Operative obstetrics. Reference has been 
drawn to its value in the provision of 
anaesthesia for delivery of the after«coming 
head in assisted breech delivery. In this 
situation, administration of cyclopropane 
coincides with a point in parturition at which 
placental transmission ceases and the main 
argument against the display of the drug is 
not relevant. Routine assessment of all 
newborn infants by the Apgar system is employed 
by the author, and this latter statement concerning 
cyclopropane is supported by the fact that in all 
breech deliveries occurring in the current study, 
the score at I minute was 10.
Hodges, Bennett and Tunstall (1959) 
demonstrated a marked contrast in viability 
between babies born after the display of nitrous 
oxide ; muscle relaxant anaesthesia and after 
ether anaesthesia. whereas newborn infants of 
the former group were hardly affected, the 
incidence of neonatal respiratory depression 
following ether techniques was very high, more
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80 than after trimethylene or triohlorothylene 
sequences.
There are probably few Indications for 
the exhibition of ether in an obstetric unit 
that boasts of a specialist anaesthetic service 
In consideration of the incidence of foetal 
depression following ether anaesthesia, a very 
good case must exist for display of this agent 
when the operation is likely to culminate in 
delivery of the baby. It is believed that the 
existence of maternal pre-eclampsia is such an 
indication. In this connection, it is to bo 
stressed that, in order to inhibit the pressor 
effect of hrC)Ometrine, vaporization of ether 
need not commence until delivery is imminent*
In this way, not only is maternal safety 
guaranteed, but the occurrence of foetal 
depression is unlikely.
The vasodilatation that results from 
inhalation of di-ethyl ether tends to persist 
for some considerable time after termination 
of the anaesthesia (Robertson, 1957). This
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particular attribute might be expected, therefore, 
to protect the patient during the immediate 
poat-anaesthetic period until the tendency to 
react to Ergometrine has passed off*
The number of drugs that exert their main 
pharmacological action, without at the same time 
producing undesirable side-effects, must be very 
small and Ergometrine certainly cannot be 
included among them* Nevertheless, it must be 
stressed that, as well as being an agent that 
holds potential dangers for patients whose 
vasoconstrictor mechanism has been sensitized by 
administration of a vasopressor agent or by the 
presence of pre-eclamptic toxaemia, Krgometrino 
has oeen shown by the results of this inquiry to 
be a remarkably safe drug for adminlstration to 
normotemslva women and to those suffering from 
chronic hypertensive cardiovascular disease. It 
would be wrong, therefore, to conclude this 
discussion without stating that the findings of 
this investigation in no way call for any
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modification of the routine administration of 
Ergomotrine to normotensive women who, after all, 
form the greater number of our patients.
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CONCLUSIONS
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CONGLUSXQNS*
In a study of pregnant patients who required 
general anaesthesia for operative or instrumental 
delivery, 0.5 mg. ErgOrne trine male a te was given 
intravenously as an oxytooic agent following
-“N
/ delivery of th© child,- and the circulatory
response observed. a s a result of this 
1^0 investigation it is concluded that : -
(1) Ergometrine does not evoke a significant
vasopressor response in normotensive
women after delivery of a single foetus,
) women who ^ive birth to twins are
likely to show an elevation of blood 
pressure after intravenous 
administration of the drug,
(3) n marked rise in systolic and diastolic 
blood pressures, in many oases exceeding 
20 mm.Hg*, is the general rule in 
patients suffering from hypertensive 
toxaemia of pregnancy,
(4) when ante-natal hypertension is due
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to established chronic vascular 
disease, there is xio danger associated 
with the administration of Ergometrine,
(5) Modern techniques of anaesthesia that 
preserve the integrity of the 
vasoconstrictor mechanism, offer no 
protection from the vasopressor 
activity of this oxytocic drug. In 
this respect, vasodepressant techniques 
employing di-ethyl ether, halo thane,
or cyclopropane have been shown to have 
a definite inhibitory effect on the 
pressor response,
(6) The papaverine - like effect attributed 
to pethidine is too weak to counteract 
the hypertensive action of Ergometrine,
(7) hypertension during labour Is not an
(L
index of^possibility of occurrence of 
the Ergomotrine effect. Only the 
basal level of blood pressure has 
been established as having any 
significant relationship to the
128
circulatory response
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aPPEMDIX h.
V/iSOPfiESSOB EPPECT OP BBGOMETRINE BLOOD PRESSURE READINGS
IN  169 iüORMOÏENSIVE «OMEN UNDER NI'l'ROUS OXIDE, OXÏGEN,
RELAXa NT ANAESTRESlA.
Xdentif
cation
i'iumber*
Basal BP BP before 
l,r^ome trine
Rise 3 mlns. 
after I.V. Remarks 
Er^ometrine 
mm.%.
!• 29. 105/60 120/84 4/2
2. 27. 110/60 150/94 o /o
3. 31. 100/65 108/70 0/4
4. 34. 100/65 160/118 6/0
5. 28. 105/66 152/128 2/0
6 • 40. 110/65 120/76 o /o
7. 39. 116/66 130/86 o /o
8. 23. 125/65 128/76 10/6
9. 21. 100/66 146/104 0/0
10. 26. 110/66 144/112 16/10
11. 26. 112/68 140/90 0/4
12. 24 . 120/70 120/94 0/0
13. 41. 100/70 122/86 o /o
14. 27. 100/70 110/76 o /o
15. 20. 100/70 110/74 o /o
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a p p e n d i x  a  t o o n t l n u e â ) .
VASOPRESSOR EPPECT OB' ERGOmTRINE BLOOD PRESSURE READINGS
IN  169 H0RM0TEN3IVE «OMEN UNDER NITROUS OXIDE, OXYGEN,
RELAXANT a n a e s t h e s i a.
Identifi­
cation 
Number.
Age. Basal BP 
mm.Hg.
BP before 
Ergometrine 
mm.Eg.
Rise 3 mlns. 
after I.V. Remarks 
Ergometrine 
mm.Eg.
16, 24 . 100/70 150/92 0/0
17. 32. 100/70 116/84 o /o
18. 36. 105/70 180/86 o /o
19. 25. 105/70 154/108 o /o
20. 28. 105/70 130/98 o /o
21. 33. 106/70 138/114 8/2
22. 22. 110/70 124/88 G/4
23. 29. 110/70 160/96 o /o
24. 24. 110/70 90/66 o /o
25. 40 . 110/70 150/94 o /o
26. 40. iiO/70 110/72 o /o
27. 32. 110/70 118/70 o /o
28. 28. 110/70 128/84 o /o
29. 26. 110/70 110/70 o /o
30. 4.1 » 110/70 138/90 2/2
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APPENDIX A (c o n t in u e d ) .
VASOPRESSOR EPPECT Op ERQOMETRINE BLOOD PRESSURE READINGS
IN  169 N0RM0ÏENSIVB «OMEN UNDER NITROUS OXIDE, OXYGEN,
RBLAXAN T ANAES THESlA.
Identifi­
cation
Humber.
Age. Basal BF 
mm.Eg.
BF before 
Ergometrine 
mm.Eg.
Rise 3 mlns. 
after I.V. Remarks 
Ergometrine 
mm.Eg.
31. 42. 110/70 1B4/8S o /o
32. 28. 110/70 100/70 o /o
33. 22. 110/70 110/70 o /o
34. 25. 110/70 158/116 0/0
35. 37. 110/70 134/76 6/4
36. 31. 110/70 100/70 0/0
37. 21. 110/70 110/80 o /o
38. 42. 110/70 110/70 0/0
39. 27. 110/70 136/102 12/10
40. 21. 110/70 136/102 12/10
41. 25. 114/70 116/70 o /o
42. 30. 114/70 132/86 2/0
43. 28. 114/70 138/W6 o /o
44. 36. 114/70 114/70 6/10
45. 31. 115/70 138/94 o /o
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APPENDIX A (c o n tin u e d J .
VASOPRESSOR EP'PEGT OP' Ei^GOiUETRINE BLOOD PRESSURE READINGS
In  169 NORMOÎENSIVE «OJVîEN UNDER NITROUS OXIDE, OXYGEN,
RELAXANT ANAESTHESIA.
Identif1
cation
Humber,
•• AgeI. Basal BP 
mm.Hg.
BP before 
Ergometrine 
mm.%.
Hi30 3 mlas. 
after I.V. Remarks 
Ergometrine 
mm.Eg.
46, 23. 115/70 156/106 o/o
47. 33. 116/70 114/70 o/o
48. 27. 116/70 142/98 o/o
49. 32. 130/70 164/100 o/o
50. 24. 130/70 130/70 0/2
51. 20, 120/70 140/82 4/0
52. 40, 120/70 110/70 4/0
53. 31. 120/70 140/84 0/4
54. 20. 130/70 133/80 0/0
65. 27. 130/70 166/128 o/o
56. 28. 130/70 120/76 0/4
57. 30. 120/70 166/120 0/0
58. 41. 180/70 142/80 0/0
59. 22. 135/70 130/70 o/o
60. 26. 136/70 130/72 o/o
61. 41. 130/70 140/84 o/o
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VASOPBBSaOR EBî 
In 169
APPENDIX A (o o n tln u e c i) .
*'ECT OB' ERQOMETRINE BLOOD PRESSURE READINGS 
SIVE «OMEW UNDER NITROUS OXIDE, OXYGEN,
r e l /'uvaht a n a e s t h e s i a.
Identlf1-
cation
Humber.
- Age. Basal Bp 
mm.%.
BP before 
Ergometrine 
mm.Mg.
Rise 3 mina. 
after I.V. Remarks 
Ergometrine 
mm.Ig.
6 2. 24. 100/72 120/80 o/o
63. 25. 124/78 170/184 o/o
64. 27. 110/74 114/76 4/4
65. 39. 120/74 130/80 10/6
66. 41. 120/74 182/124 2/0
67. 32. 186/74 164/180 o/o
68. 31. 105/75 118/84 12/6
69. 31. 110/75 140/94 42/a Twin Preg
70. 26. 110/75 140/82 o/o
71. 21. 120/75 162/116 o/o
72. 20. 120/75 lir,0/SS o/o
73. 29. 120/75 142/100 o/o
74. 30. 125/75 110/74 16/16
76. IB. 108/76 150/100 10/4
76. 38. 110/76 180/80 o/o
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a FPEHDIX a ( cont5-nued ),
VASOPRESSOR EFB'ECT OF EROOmTRIHE BLOOD PRESSURE READINGS
In 169 HORMOIKWSIVE vVOMEN UNDER NITROUS OXIDE, OXÏÛEH,
RELaXa NT AHAESTiiESIa,
Identifi­
cation 
Number•
Age « Baeal BP 
rnm.Bg.
BP before 
Ergometrine 
mm.%.
Ri 80 3 mine. 
after I.V^ Remarks. 
Ergom©trine 
mm.%.
77. 20. 110/76 128/86 R6/18 T«i/in Pregnancy.
78. 29. 110/76 110/76 o/o
79. 23. 114/76 110/76 o/o
80. 38. 118/76 126/90 4/0 TT/ln Pregnancy.
81. 22. 180/76 138/86 8/4
82. 21. 120/76 180/74 4/2
83. 40. 124/76 124/88 4/2
84. 32. 184/76 144/106 0/0
85. 33» 130/76 150/96 0/2
86. 29. 100/78 140/100 0/0
87. 45. 140/78 134/90 60/50
88. 43. 102/80 158/126 92/20 Syntocinon Drip.
89. 26. 105/80 104/78 0/0
90. 26. 110/80 112/80 12/10
91. 37. 110/80 160/118 0/0
92. 26. 110/80 126/88 2/2
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appendix a  (continued).
VASOPhEaSUK EFFECT EKGO&iETEXNE BLOOD PRESS URL READINGS 
IN 169 NOHMOTLNSIVE #OMEN UNDER NITROUS OXIDE, OXYGEN,
RELAXANT AMESTRESXa .
Idantlf i'
cation
Number.
Age* Basal BP
mm,
BP before 
Ergometrine 
mm.%.
Rise 3 mlns. 
after I.V. Remarks 
Ergometrine 
mm.
9 3 . 2 9 . 1 1 0 /8 0 1 8 8 /1 0 0 8 /0
9 4 . 32 . 1 1 0 /8 0 1 1 0 /7 4 0 /0
9 5 . 2 3 . 1 1 0 /8 0 1 1 0 /8 0 o /o
9 6 . 2 3 . 1 1 0 /8 0 1 1 6 /8 6 o /o
9 7 . 2 9 . 1 1 0 /8 0 1 1 4 /8 8 0 /0
9 8 . 32 . 1 1 0 /8 0 1 5 6 /1 0 4 2 /0
9 9 . 2 0 . 1 1 0 /8 0 1 1 0 /7 4 0 /0
1 0 0 . 2 5 . 1 1 0 /8 0 1 1 0 /7 0 2 6 /8
1 0 1 . 2 8 . 1 1 8 /8 0 1 3 0 /9 8 1 0 /4
102. 2 4 . 1 1 5 /8 0 1 3 4 /1 0 0 4 /0
1 0 3 . 1 9 . 1 1 6 /8 0 1 3 6 /9 8 1 0 /8
1 0 4 . 2 6 . 1 1 6 /8 0 1 3 0 /9 4 2 0 /1 4
1 0 5 . 3 4 . 1 1 8 /8 0 1 4 0 /1 0 4 3 4 /1 8
1 0 6 . 3 8 . 1 1 8 /8 0 1 2 0 /8 0 4/0
1 0 7 . 3 3 . ik o /a o 1 3 4 /1 0 8 0 /0
1 0 8 . 2 4 . ia O /8 0 1 4 0 /9 8 0/0
Twin Pregnancy,
Twin Pregnancy 
Twin Pregnancy
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APPENDIX A (continued). .
VASOPRESSOR EP'FECT OB' ERGOMETRIHE BLOOD PRESSURE READINGS
IN  169 HOI iS IV E  kVOMm HITROU
RELAÀJ'VH T .mHa LSTBKB I / i
8  O XID E , OXYGEN,
Identifi­
cation
Humber,
Age. Basal BP 
rmïi.Bg.
op before
Ergometrine 
mm,%.
Eise 3 mins. 
after I.V, Remarks. 
Ergometrine 
mm .Eg *
109. 3 2 , 120/80 158/106 12/ a
110, 2 3 . 120/80 130/86 1 0 /6
111, 2 3 . 120/80 146/114 6/4
112. 3 5 . 120/80 110/74 o /o
1 1 3 , 33, 120/80 120/84 16/12
1 1 4 . 35, 120/80 124/84 6 /2
115, 27. 120/s o 130/86 o /o
116. 3 8 . 120/80 180/80 o /o
117. 3 0 . 120/80 120/86 6/2
1 1 8 . 3 5 . 120/80 124/80 0/0
1 1 9 . 33. 120/80 160/104 0/4
120. 40, 120/80 180/108 o /o
121, 42. 120/80 140/08 o /o
132. 3 3 . IB O /e O 186/84 0/2
123. 26, 120/80 136/86 4/0
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APPENDIX A (continued).
VASOPRESSOR EFFECT OF ERGOMETRIHE BLOOD PRESSURE HEADINGS
IN 169 NORMOTEHSIVE lAfOMEN UNDER NITROUS OXIDE, OXYGEN,
r e l a x a n t ANAESTBESXA.
Identifi­
cation 
Number.
Ago. iaaal BP 
mm.%.
BP before
Ergometrine 
mm.Hg.
Else 3 mlns. 
after I.V. Remarks< 
Ergometrine 
mm.Eg.
124. 30. 1 2 0 /8 0 1 4 6 /1 1 0 0 /0
125. 21. lis o /a o 1 2 0 /8 0 o /o
1 2 6 , 2 1 . 1 2 0 /8 0 1 2 0 /8 0 o /o
1 2 7 . 2 8 . 1 2 0 /8 0 1 1 0 /6 6 o /o
1 2 8 . 2 3 . 1 2 0 /8 0 1 4 0 /1 0 0 o /o
1 2 9 , 21. 1 8 0 /8 0 1 3 0 /9 2 o /o
1 3 0 . 32. 1 2 0 /8 0 1 1 0 /8 0 1 0 /4
131. 38. 1 2 0 /8 0 1 4 4 /1 1 2 2 6 /26 Oedema a 
Albuminu
1 3 2 . 2 1 . 1 2 0 /8 0 1 0 8 /7 0 o/o
1 3 3 . 25. 1 2 0 /8 0 1 3 0 /8 4 0/0
1 3 4 . 23 « 1 2 0 /6 0 1 4 6 /1 1 0 o /o
1 3 5 . SB. 1 8 4 /8 0 1 2 0 /8 2 0 /8
1 3 6 . 19. 1 2 4 /8 0 1 4 0 /1 8 0 6 /0
1 3 7 . 23. 1 2 4 /8 0 1 3 0 /9 0 o /o
1 3 8 . 2 7 . 1 2 4 /8 0 1 4 6 /ia O 6 /0
1 3 9 , 2 5 . 1 2 6 /8 0 1 1 6 /7 6 4/4
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AFPEMDIX A (oontinuedj.
VASOPRESSOR EBFECï OF IROOm'lKIME BLOOD PRESSURE READINGS
IN 169 NORMOTEKSIVE «OMBK UNDER NITROUS OXIDE, OXYGEN,
RELAXA.NÏ ARABS THES lA.
Identifi- Age. Baael BF
cation
Humber *
mm* Mg
BP before Hlse 3 mins.
Ergometrine after I.V. Remarks.
mm. ometrine
e»ee w*i»<iwiuiF |iiîie «iNteJV’iW iW
mm.%.
140. 32. 185/80 160/84 10/6
141. 29. 185/80 124/92 2/0
142. 34 « 126/80 140/86 0/0
143. 36. 186/80 168/114- 0/0
144. 25. 186/80 180/114 o /o
145. 17. 186/80 130/86 14/8
146. 21. 130/80 160/124 12/6
147. 22. 130/80 138/110 6/0
148. 39. 130/80 160/124 o /o
149. 23. 130/80 140/84 0/0
150. 15. 130/80 120/76 10/8
151. 26. 130/80 130/92 o /o
152. 21. 135/80 146/68 14/10
153, 29. 140/80 140/80 6/4
154. 88. 130/88 140/94 o /o
155. 0 180/84 132/86 2/0
Twin Pregnancy
133
ÀPPLHDÎX A (continued),
VASOPRESSOR EFT EOT Œ  AKGOÆThlHE BLOOD FEES SUEE REAIi H0S 
IN 169 HOKMOTEkSIVE v^ OMEH UiSDEK NITROUS OXIDE, OXYGEN,
RELAXANT iUvA EBThRSlA,
Idantifi 
cation 
Number #
Aga» Eaoal BP BP before
mm•Eg• Ergomatrine
mm
HI00 3 mlns. 
af ter I,V . Remarks. 
Ergometrine
mm. 11£
1 5 6 . 2 4 . 1 2 0 /8 4 1 6 4 /1 2 0 2/0
1 5 7 . 3 7 . 1 2 0 /8 4 1 3 0 /9 0 0/0
1 5 8 . 2 6 . 1 2 0 /8 4 1 4 2 /1 0 8 4/8
1 5 9 . 2 1 . 1 2 0 /8 4 1 5 8 /1 0 0 o /o
1 6 0 . 2 0 . 1 2 0 /8 4 1 3 6 /9 6 0/0
1 6 1 . 4 1 . 1 2 6 /8 4 1 8 4 /1 2 8 0 /0
1 6 2 . 8 0 . 1 3 0 /8 4 1 5 2 /1 1 8 0/0
1 6 3 . 2 3 . 1 1 0 /8 5 1 3 4 /9 8 0/2
1 6 4 . 2 0 . 1 1 0 /8 5 1 2 6 /9 2 0/0
1 6 5 . 2 6 . 1 1 5 /8 5 1 3 2 /9 6 2/0
1 6 6 . 1 9 . 1 8 0 /8 5 1 3 4 /9 4 4/4
1 6 7 . 3 6 . 1 1 0 /8 6 1 6 6 /1 3 0 4/4
1 6 8 . 19 . 1 1 8 /8 6 1 2 4 /9 4 2/0
1 6 9 . 2 3 . 1 2 8 /8 8 1 5 6 /1 2 0 0/0
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APPENDIX B.
VASOFHESSOH EFFECT OF EEGOMETHINK MALBATE « READINGS OF 
BLOOD PRESSURE IN 53 WOMEN WITH BASAL DIaSTOLIC PRESSURE 
OF 90 - 99 mm.Hg, AND aNaESTMETIEED BY NITROUS OXIDE, 
OXYGEN, RELAXANT TEGBND4ÜE,
Identifl- Age
cation
Number,
Basal BP BP before Rise 3 mins# 
mm.Mg. Ergometrine after I.V. Remarks, 
mm « Eg. Ergom© trine
mm.Hg.
1. 30. 120/90 104/86. 26/16
2. 29. 180/90 100/70. o /o
3. 20. 180/90 110/86 o /o
4. 25. 120/00 150/108 14/18
6. 33. 120/90 110/86 4/4
e . 29. 12a/90 108/80 0/0
7. 21. 126/90 136/108 6/12
8. 33. 126/90 130/98 10/8
9. 23. 130/90 126/90 4/2
10. 37. 130/90 130/92 lO/lO
11; 25. 130/90 146/100 6/4
12; 21. 130/90 130/90 0/0
13. 22. 130/90 140/94 0/4
14. 28. 130/90 128/90 12/4
Severe
Hydramnios.
Syntocinon Drip
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APPENDIX B (continued).
VASOPKESSOH EPPECT OP ERGOMÎHINE MALEATE - KEADIWGS OP 
BLOOD ®p:aSURE IN 63 fO&lEH «ITB BASAL DIASTOLIC PRESSURE 
OF 80 - 99 mm.Hg. AND aRAESTEETIZED BY NITROUS OXIDE,
OXYGEN, RELAXANT TEGENlqUE.
Identlfi- Age. Basal BP BP before 
catIon mm•Eg. Brgome trine
Humber. mm.Hg.
Rise 3 mlns. 
after I.V. Remarks 
Krgometrine 
mm,
16. 20. 130/80 lBO/88 0 /2
16. IB. 130/90 168/114 o /o
17* 36. 130/90 146/98 4 /4
18. 23. 130/so 126/90 1 0 /6
19. 21. 130/90 140/106 10 /4
20. 37. 130/80 170/126 o/o
21. 36. 130/90 140/94 16 /10
22. 41. 130 /90 140/96 1 6 /8
23. 30. 130 /90 124/76 18 /10
24. 17. 130/90 146/114 18 /10
25. 25. 135/90 140/92 16 /10
26. 42. 140/80 118/74 20 /14
27. 19. 140/90 138/90 8/0
28. 39. 140/90 134/90 1 8 /8
29. 23. 140/90 126/96 18 /4
Renal
Glycosuria
Diabetic.
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APPENDIX B (CONTINUED).
VASOPKESSOK EPPECT OF ERQOMETRINE MALBAÏE - READINGS 0?
■ '6,
BLOOD PRESSURE IN 53 WOMEN WITH SaSAE DIASTOLIC PRESSURE 
OP 90 - 99 m m , %  AND ANAESTHETIZED BY NITROUS OXIDE,
OXYGEN, RELAXANT TECRNIw^UE.
Identifi­
cation
Humber.
t *  MW .4.  ***«
Age. Basal BP 
mm.Hg.
BF before 
Krgo/ue tr in© 
mm.%.
Hlae 3 mins. 
after I.V, Remarks. 
Ergometrine 
mm.Hg.
30. 31. 140/90 154/116 4/6
31. 33. 140/90 130/90 lO /lO
32. 35. 140/90 158/118 12/16
33. 25. 150/90 180/146 16/4
34. 28. 150/90 150/88 22/20
36. 38. 156/90 142/84 10/4 Chronic
Hypertension.
36. 32. 120/92 146/110 o /o
37. 30. 130/94 152/106 16/10
38. 25. 130/04 138/96 10/8
39. 24. 132/94 160/118 10/10
40. 23. 130/95 120/92 14/12
41. 24. 135/96 160/90 30/20 Twin Pregnancy
42. 22. 140/95 156/108 BP fell to 126/84 mm.Hg.
43. 24. 145/95 180/116 o /o Chronic 
nephritis.
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a p p e n d i x b (continued). 
Va SOPRBSü OB EPPECT OF EkGOl/E'iKIWE ivCtLEAXB READINGS OP
BLOOD PJ 
OF 90 -
RESBURE 
99 nim.i
IH 53 ÆOMEH WITH BASAL 
%. A m  aHAESTRETlAED BY 
OXYOER, RELAXANT ÏECEI'
DIASTOLIC PRESSURE 
: NITROUS OXIDE, 
atjUE.
Idontifi- Age, 
cation
Basal BP 
nrm. Rg.
BP uei ore 
Ergometrine
îîllli. .
Rise 3 mlns. 
after I.V. Remarks. 
Ergometrine 
mm • % .
44. 37. 145/95 164/116 46/24
45. 40. 150/95 168/118 2/0 Chronic
46. 29. 150/95 144/90
Hypertension
20/10
47. 23. 155/95 150/96 30/24
48. 30. 130/96 130/96 18/8
49. 28. 134/96 164/120 10/10
50. 18. 140/96 140/96 14/10
51. 22. 140/96 164/138 16/14
52, 38. 148/96 176/134 o /o  Chronic
53. 40. 140/98 140/100
Hypertension 
BP fell to 90/60 mm.l
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APPENDIX G.
VASOPRESSOR EPPECT OP ERGOffiTRIHE MALEAÏE - READINGS OP 
BLOOD PRESSURE IN 31 WOMEN WITH BASAL DIASTOLIC PRESSURE 
OP 100 mm.Hg. OR MORE, AMD ANAESTHETIZED BY NITROUS 
OXIDE, OXYGEN, RELAXANT TECHNIQUE.
Identifi­
cation
Number.
Age. Baeal BP 
mm *Ig.
B? before 
Brgometrine 
mm.Hg.
Els© 3 mlns. 
after I.V. Remarks. 
Ergometrine 
min. lig.
lo 81. 130/100 120/98 40/24
2. 86. 140/100 160/114 10/6
3. 18. 140/100 170/118 0/2 Syntocinon
4* 31. 140/100 140/100 40/24
&• 22. 140/100 148/98 18/10
a. IB. 140/100 104/72 40/26
7. S3. 140/100 140/100 30/28
8. 24. 146/100 176/122 20/24
9. 31. 150/100 140/100 80/8
10. 27. 150/100 140/100 20/14
11. 26. 150/100 160/100 20/10
12* 37. 160/100 160/100 36/26
13* 37. 160/100 160/112 12/6 Chronic
Bypertensii
14. 32. 130/104 150/110 10/4
15. 23. 160/105. 130/86 36/26
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APPENDIX C (continued).
VASOPRESSOR EPPECT OP ERQOMETRINE MALEATE - READINGS OF 
BLOOD PRESSURE IK 31 WOMEN «ITR Ba Sa L DIASTOLIC PRESSURE 
OF 100 inm.fcife. OK MORE, AND a NaESTHETIZED BY NITROUS 
OXIDE, OXYGEN, RELAXANT TEGHNIh UE.
Identif1- 
cation 
Humber *
Ag©. Basal BP 
mm.Hg.
BP before 
Ergometrine 
mm.Hg.
Rise 3 mins. 
after I.V. Remarks. 
Ergometrine 
mm.Hg.
16. 29. 130/106 146/116 14/10 Twin Pregnancy.
17. 37. 150/106 198/150 8/4 Chronic
Hypertension.
18. 44. 160/108 184/116 6/0 Chronic 
Hypertension.
19. 39. 160/108 198/188 8/2 Chronic 
Hypertens!on•
20. 30. 148/110 150/122 80/18
21. 22. 160/110 154/110 28/20
22. 21. 166/110 170/120 BP fell to 150/l06 mm.Hg
23. 35. 170/110 164/110 o/o
24. 34. 180/110 180/100 80/10
25. 23. 180/110 180/82 40/30
26. 30. 800/110 150/108 40/88
27. 36. 144/116 184/134 o /o Chronic
Hypertension.
28. 42. 190/116 144/96 o /o Chronic 
Hypertens ion.
29. 30. 150/180 150/118 6/0 Chronic
Hypertension.
30. 27. 160/120 154/124 0/0 Twin Pregnancy 
under tribromothanol 
narcosis.
31. 39. 880/135 184/106 4/0 Chronic
Hypertension.
